Copy of Order dated 09-OCT-2019 rendered by Chief Justice Crampton concerning the destruction of exhibits tendered into evidence placed on file. Original filed on Court File No. T-967-76

Solicitor's certificate of service on behalf of Jane Caskey confirming service of Doc 228, 229 upon Plaintiff by telecopier on 15-MAY-2014 filed on 15-MAY-2014

Discontinuance on behalf of the parties filed on 15-MAY-2014

Consent on behalf of all parties to the filing of the notice of discontinuance attached hereto as schedule A filed on 15-MAY-2014

Payment of Court fees (ARV#1475) in the amount of $350.00 recd on Apr. 14, 2014 from Goodmans LLP and placed on file Apr. 23, 2014

Payment of Court fees (ARV#1477) for the amount of $350.00 received from Sprigings Intellectual Property Law on April 15, 2014

Payment of Court fees (ARV#1478) in the amount of $1,050.00 received from Norton Rose Fulbright Canada LLP on April 10, 2014

Payment of Court fees in the amount of $350.00 (ARV#1476) received from Gardiner Roberts LLP on April 7, 2014

Request for payment of Court fees (ARV#1478) in the amount of $1050.00 sent to Norton Rose Fullbright LLP placed on file on 21-MAR-2014

Request for payment of Court fees (ARV#1477)in the amount of $350.00 sent to Sprigings Intellectual Property Law placed on file on 21-MAR-2014

Request for payment of Court fees (ARV#1476) in the amount of $350.00 sent to Gardiner Roberts LLP placed on file on 21-MAR-2014

Request for payment of Court fees (ARV#1475) in the amount of $350.00 sent to Goodmans LLP placed on file on 21-MAR-2014

MEMORANDUM to Case Management Judge, Aronovitch, P., from Cynthia Leaver, Ottawa Registry, enclosing copy of DISCONTINUANCE filed 3-MAR-2014 in Federal Court of Appeal file A-397-13 (consolidated with A-398-13) placed on file on 06-MAR-2014

Copy of NOTICE OF DISCONTINUANCE in Federal Court of Appeal file # A-397-13 (consolidated with A-398-13) placed on file on 06-MAR-2014 Original filed on Court File No. A-397-13

List of Exhibits on behalf of all parties received at hearing on 14-FEB-2014

List of Exhibits on behalf of Plaintiff- Apotex Inc. received at hearing on 13-JAN-2014

Toronto 13-JAN-2014 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Trial in this action Result of Hearing: Matter adjourned sine die held in Court Senior Usher: Lisa Tirado 13-JAN-2014 Lisa Tirado 14-JAN-2014 Lisa Tirado 15-JAN-2014 Mike Gaida 20-JAN-2014 Mike Gaida 21-JAN-2014 Mike Gaida 23-JAN-2014 Mike Gaida 24-JAN-2014 Greg Nevin 27-JAN-2014 Greg Nevin 28-JAN-2014 Joe Mischuk 29-JAN-2014 Joe Mischuk 30-JAN-2014 Joe Mischuk 31-JAN-2014 Frank Kurina 03-FEB-2014 Noel Nation 04-FEB-2014 Frank Kurina 05-FEB-2014 Frank Kurina 06-FEB-2014 Lisa Tirado 10-FEB-2014 Duration per day: 13-JAN-2014 from 09:35 to 04:10 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 14-JAN-2014 from 09:30 to 02:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 15-JAN-2014 from 09:30 to 12:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 20-JAN-2014 from 09:30 to 12:10 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 21-JAN-2014 from 09:28 to 04:20 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 23-JAN-2014 from 09:28 to 11:45 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 24-JAN-2014 from 09:32 to 11:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 27-JAN-2014 from 09:30 to 11:25 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 28-JAN-2014 from 09:30 to 10:25 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 29-JAN-2014 from 09:30 to 04:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Shirley Aciro 30-JAN-2014 from 09:30 to 05:30 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 31-JAN-2014 from 08:58 to 10:19 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 03-FEB-2014 from 09:28 to 05:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 04-FEB-2014 from 09:28 to 04:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 05-FEB-2014 from 09:29 to 05:02 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 06-FEB-2014 from 09:27 to 04:57 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 10-FEB-2014 from 09:30 to 04:33 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith Total Duration: 17d Appearances: Mr. Harry Radomski 416-979-2211 representing Plaintiff Mr. jerry Topolski 416-979-2211 representing Plaintiff Mr. David Scrimger 416-979-2211 representing Plaintiff Ms. Jenene Roberts 416-979-2211 representing Plaintiff Mr. Ken Crofoot 416-979-2211 representing Plaintiff Ms. Carol Hitchman (T-2101-09) 416-865-6600 representing Plaintiff Ms. Alisse Houweling (T-2101-09) 416-865-6600 representing Plaintiff Mr. Warren Sprigings (T-643-10) 416-777-0888 representing Plaintiff Mr. Christopher Tan (T-643-10) 416-777-0888 representing Plaintiff Mr. Patrick Kierans 416-216-4000 representing Defendant Ms. Jordana Sanft 416-216-4000 representing Defendant Mr. Daniel Daniele 416-216-4000 representing Defendant Ms. Jane Caskey 416-216-4000 representing Defendant Ms. Amy Grenon 416-216-4000 representing Defendant Exhibits filed at hearing: A-1 to A-56 APO-1 to APO 3 GSK-1 to GSK 22 Witness(es) on behalf of Plaintiff Dr. Robert Langer Cambridge, Mass. USA on behalf of Plaintiff Dro. Jonathan Dordick Schenecyady NY, USA on behalf of Plaintiff Dr. Stephen Hanessian Beaconsfield, QC Canada on behalf of Plaintiff Dr. Clyde s. Crumpacker Boston MA, USA on behalf of Plaintiff Dr. Michael Mayersohn Marana Arizona, USA on behalf of Plaintiff Dr. Paul A. Laskar Napa, CA, USA on behalf of Defendant Dr. Hans Maag Murnau, Germany on behalf of Defendant Dr. Stephen Graham Davies Oxford, UK on behalf of Defendant Dr. Jennifer Dressman Frankfurt, Germany on behalf

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed on 11-FEB-2014 212 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed on 11-FEB-2014 301 pages (including covering pages).

Solicitor's certificate of service on behalf of Jesse Todres confirming service of doc. 223 upon Plaintiff by telecopier on 20-JAN-2014 filed on 20-JAN-2014

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed on 07-FEB-2014 225 pages (including covering pages).

Notice under the Canada Evidence Act on behalf of Defendants and Plaintiffs by Counterclaim filed on 20-JAN-2014

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 05-FEB-2014 212 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 04-FEB-2014 288 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 03-FEB-2014 54 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 31-JAN-2014 207 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 30-JAN-2014 182 pages (including covering pages).

Writ of Subpoena Ad Testificandum directed to the Sheriff of MONTREAL, QC issued on 29-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 29-JAN-2014 Tariff any other proceeding - $30.00

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed on 29-JAN-2014 40 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 28-JAN-2014 82 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 27-JAN-2014 99 pages (including covering pages).

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 24-JAN-2014 Tariff any other proceeding - $30.00

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 24-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum to Glenn Monteith pursuant to the Order of Justice Manson dated 10-JAN-2014 issued on 24-JAN-2014 cc filed

Writ of Subpoena Ad Testificandum to: Kelly Uyeno pursuant to the Order of Justice Manson dated 10-JAN-2014 issued on 24-JAN-2014 cc filed

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 24-JAN-2014 90 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 23-JAN-2014 227 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed on 21-JAN-2014 114 pages (including covering pages).

Acknowledgment of Receipt received from all parties with respect to doc. 204 & 205 - Reasons for Order and Order dated 20-jan-2014 and Certificate of Order dated 20-jan-2014. placed on file on 20-JAN-2014

Certificate of Order respect to the Reasons for Order (doc. 204_) filed on 20-JAN-2014

Reasons for Order and Order dated 20-JAN-2014 rendered by The Honourable Mr. Justice Manson Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 187 Result: PMS and Apotex's motion is granted with respect to paragraphs 1-13, 17-21 and 27-34 of the Affidavit of Dr. Paul Laskar. 2) PMS and Apotex's motion is otherwise dismissed, 3) Costs to GSK in the cause. Filed on 20-JAN-2014 certified copies sent to parties Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1217 page(s) 186 - 186

Book of Authorities consisting of 1 volume(s) on behalf of Pharmascience Inc. received on 09-JAN-2014

Sealed envelope pursuant to Order dated 29-Sept-2010 on behalf of Pharmascience Inc purporting to contain Motion Record of Pharmascience Inc, Motion for Reply Expert Evidence Filed on 09-JAN-2014

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 20-JAN-2014 136 pages (including covering pages).

Solicitor's certificate of service on behalf of Daniel Daniele confirming service of doc 200 & Book Authorities upon Plaintiff by personal service on 16-JAN-2014 filed on 16-JAN-2014

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 16-JAN-2014

Sealed envelope pursuant to protective order dated:29-sep-2010 on behalf of Defendant purporting to contain The Defendant-GSK's responding Motion Record- (doc 198-199)in response to Plaintiff's -Motion Doc. 187 Filed on 16-JAN-2014

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 187 filed on 16-JAN-2014

Affidavit of Scott Werry sworn on 16-JAN-2014 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 187 with Exhibits a-n filed on 16-JAN-2014

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 15-JAN-2014 151 pages (including covering pages).

Transcript of (CONFIDENTIAL- SUBJECT TO PROTECTIVE ORDER)hearing held at Toronto filed at hearing on 14-JAN-2014 Sent directly to presiding Judge 214 pages (including covering pages).

Expert Reports of Rosemary A. Bacovsky, Dr. Christine Meyer, Report on Valacyclovir,Documents referred to in the FTI Report dated Jan 7, 2014, Booklet from Duff & Phelps received on 14-JAN-2014

Letter from APOTEX INC. dated 14-JAN-2014 "We ask that this letter and its attachments be referred to Mr. Justice Manson, the trial judge...In accordance with the Court's request to be provided with copies of the experts reports, we enclose briefs containing Apotex's expert reports dealing with the damages claim by GSK as follows: Report of Andrew Harington;Report of Rosemary Bacovsky; Report of Howard Rosen; Report of Dr. Christine Meyer...These reports were served on counsel to GSK last week accordance with the agreed schedule." received on 14-JAN-2014

Book of Authorities(2 Vols) consisting of 2 volume(s) on behalf of Plaintiff received on 13-JAN-2014

Brief of Depictions for Apotex Inc. filed at hearing on 13-JAN-2014

****** CANCELLED ****** Brief of Documents for Apotex Inc. filed at hearing on 13-JAN-2014

Acknowledgment of Receipt received from Defendant with respect to doc. 193 placed on file on 10-JAN-2014

Order dated 10-JAN-2014 rendered by The Honourable Mr. Justice Manson Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 189 Result: granted Filed on 10-JAN-2014 certified copies sent to parties entered in J. & O. Book, volume 1216 page(s) 185 - 194 Interlocutory Decision

Motion Record containing the following original document(s): 189 190 191 Number of copies received: 3 on behalf of Defendant - GSK filed on 10-JAN-2014

Written Representations contained within a Motion Record on behalf of Defendant - GSK concerning Motion Doc. No. 189 filed on 10-JAN-2014

Affidavit of Karen Sie sworn on 08-JAN-2014 contained within a Motion Record on behalf of Defendant - GSK in support of Motion Doc. No. 189 filed on 10-JAN-2014

Notice of Motion made ex parte contained within a Motion Record on behalf of Defendant - GSK in writing to be dealt with in the Toronto local office for an Order granting leave for the issuance to GSK of subpoenas, in the form attached hereto as Schedule "A"; other relief. filed on 10-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 09-JAN-2014 directing that Upon hearing from counsel at a case management conference on January 9, 2014 to the stipulations agreed to by the paties, the Trial in the above noted files will now commence on Monday January 13, 2014 sitting at 9:30 a.m. to 5:00 p.m. and until 12:00 p.m. on Fridays. placed on file on 09-JAN-2014 Confirmed in writing to the party(ies)

Ottawa 09-JAN-2014 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss scheduling issues in this file and T-2101-09 and T-643-10 Result of Hearing: The Court directed that the Trial of the matter would commence on Monday January 13, 2014, commencing at 9:30 a.m. to 5:00 p.m. and until 12:00 p.m. on Fridays. held by way of Conference Call Duration per day: 09-JAN-2014 from 02:00 to 02:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 30min Appearances: Mr. Radomski, Mr. Topolski and Mr. Scrimger 416-597-4142 representing Plaintiff Ms. Sanft, Mr. Kierans and Ms Caskey 416-216-4798 representing GSK Ms Hitchman and Ms Houweling 416-865-8259 representing Pharmascience Mr. Sprigings and Mr. Tan 416-777-2273 representing Pharmascience Comments: A Direction will issue shortly Minutes of Hearing entered in Vol. 895 page(s) 60 - 66 Abstract of Hearing placed on file

Sealed envelope pursuant to Order dated Sept 29, 2010 on behalf of PHARMASCIENCE INC. ET AL. purporting to contain Motion for Leave to File Reply Expert Evidence Filed on 02-DEC-2013

Notice of Motion contained within a Motion Record on behalf of PHARMASCIENCE INC. ET AL. returnable (but no hearing date indicated at this time) for An Order granting leave to Pharmascience and Apotex to file the report of an additional expert; an Order granting leave to Pharmascience and Apotex to file the reply expert reports of Dr. Gordon Amidon, Dr. Jonathan Dordick, Dr. Stephen Hanessian adn Dr. Paul Laskar...; costs of this motion.. filed on 02-DEC-2013

Acknowledgment of Receipt received from all parties with respect to the amended protective order dated 6-Jan-2014 placed on file on 06-JAN-2014

Protective Order dated 06-JAN-2014 rendered by The Honourable Mr. Justice Manson Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 166 Result: granted Filed on 06-JAN-2014 copies sent to parties entered in J. & O. Book, volume 1215 page(s) 320 - 328 Interlocutory Decision

Acknowledgment of Receipt received from all parties with respect to the amended direction of the Court dated 3-Jan-2014 (ID 660) placed on file on 06-JAN-2014

Acknowledgment of Receipt received from all parties except GSK with respect to the direction of the Court dated 3-Jan-2014 (ID 659) placed on file on 03-JAN-2014

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 3-Jan-2014 scheduling a CMC on 3-Jan-2014 at 1:30 p.m. placed on file on 03-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that having considered Ms. Hitchman's correspondence dated January 3, 2014, I amend my direction as follows: Apotex and Pharmascience shall serve and file the written representations for the motion by 2 pm on Thursday, January 9, 2014; GSK shall serve and file its responding written representations by no later than 2 pm on Thursday, January 16, 2014; The motion will be heard on January 20, 2014 placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that having considered the parties' correspondence dated January 2, 2014, I direct as follows: Apotex and PMS will complete their Motion Record including any affidavit and written argument by January 7, 2014; GSK will serve any responding affidavit by January 9, 2014; Cross-examinations on any affidavits will be completed by January 10, 2014; GSK will serve and file its responding record by January 16, 2014; The motion for leave to file reply expert report will be heard on January 20, 2014; Accordingly, the case management conference scheduled to take place today at 1:30 p.m. will not proceed placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Letter from Pharmascience in T-2101-09 dated 03-JAN-2014 advising that the parties came to an agreement re: schedule to perfect motion for leave and requesting that the direction issued earlier be amended accordingly (sent to the trial judge by e-mail on 3-Jan-2014) received on 03-JAN-2014

Covering letter from counsel for Pharmascience in T-2101-09 dated 31-DEC-2013 concerning providing a second copy of expert reports and the expert of Dr.Gordon Amidon omitted to be filed on December 10, 2013 placed on file on 02-JAN-2014

Sealed envelope pursuant to the Order of 29-Sep-2010 on behalf of Pharmascience in T-2101-09 purporting to contain Vol 3 of 3 of schedule A and B of the expert report of Dr. Gordon Amidon (only 2 copies filed and 1 sent directly to trial judge) Filed on 02-JAN-2014

Sealed envelope pursuant to the Order of 29-Sep-2010 on behalf of Pharmascience in T-2101-09 purporting to contain Vol 2 of 3 of schedule A and B of the expert report of Dr. Gordon Amidon (only 2 copies filed and 1 sent directly to trial judge) Filed on 02-JAN-2014

Sealed envelope pursuant to the Order of Sept 29, 2010 on behalf of Pharmascience in T-2101-09 purporting to contain Volume 1 of 3 of Schedule A and B of the expert report of Dr. Gordon Amidon (only 2 copies filed and one sent directly to trial judge) Filed on 02-JAN-2014

Sealed envelope pursuant to Order dated September 29, 2010 on behalf of Pharmascience in T-2101-09 purporting to contain the expert report of Dr. Gordon Amidon (only two copies filed and one sent directly to the Trial Judge)(Schedule A and B filed separately in 3 volumes) Filed on 02-JAN-2014

Certificate of Solicitor Carol Hitchman attaching thereto the proposed evidence of expert witness Dr. Gordon L. Amidon on behalf of Pharmascience in T-2101-09 filed on 02-JAN-2014

Acknowledgment of Receipt received from all parties (GSK over the phone) with respect to the direction of the Court dated 2-Jan-2014 placed on file on 02-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that a case management conference will take place on January 3, 2014 at 1:30 p.m. to discuss the scheduling of the motion for leave placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Letter from GSK dated 02-JAN-2014 in response to Apotex's letter and proposing a schedule in the event the Court directs that the motion be heard on 20-Jan-2014 received on 02-JAN-2014

Letter from Apotex dated 02-JAN-2014 advising of issues with hearing the motion for leave on the 13th and offering a potential solution which would allow the motion to be heard on 20-Jan-2014 received on 02-JAN-2014

Sealed envelope pursuant to the Protective Order dated 7 December 2009 on behalf of Apotex purporting to contain the expert report of Rosemary Bacovsky (2 copies filed and one sent directly to the Trial Judge)( attachments submitted on a stick attached to the Judge's copy document 178) Filed on 16-DEC-2013

Certificate of Solicitor Kenneth Crofoot attaching thereto the proposed evidence of expert witness Rosemary Bacovsky on behalf of Apotex filed on 16-DEC-2013

Sealed envelope pursuant to Protective Order dated 7-Dec-2009 on behalf of Apotex purporting to contain the expert report of Andrew Harington of Duff and Phelps (2 copies filed and one sent directly to the Trial Judge)(attachments submitted on a stick and attached to Judge's copy of doc. 178) Filed on 16-DEC-2013

Certificate of Solicitor Kenneth Crofoot attaching thereto the proposed evidence of expert witness Andrew Harington on behalf of Apotex Inc. filed on 16-DEC-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 02-JAN-2014 directing that GSK to serve any responding affidavits to Apotex motion materials filed December 2, 2013 by January 6, 2014; any cross-examinations on the affidavits of all parties, if any, to be conducted by January 8, 2014; GSK to file and serve its responding record by January 9, 2014; any reply and motion to be heard January 13, 2014 placed on file on 02-JAN-2014 Confirmed in writing to the party(ies)

Letter from PMS dated 31-DEC-2013 in response to GSK's letter dated 30-Dec-2013 (sent to the Trial Judge on 2-Jan-2014) received on 31-DEC-2013

Letter from GSK dated 30-DEC-2013 suggesting that Apotex and PMS' motion for leave to file reply expert evidence be heard prior to the commencement of Apotex and PMS' evidence on validity and response to infringement and requesting a direction setting timelines for perfecting the motion(Sent to the Trial Judge on 30-Dec-2013) received on 30-DEC-2013

Copy of a Letter from GSK dated 03-DEC-2013 advising the court of issues arising regarding redacted documents received on 03-DEC-2013

Copy of a Letter from GSK to all parties dated 02-DEC-2013 outlining their position regarding redacted documents received on 02-DEC-2013

Covering letter from Apotex dated 02-DEC-2013 concerning Doc. No. 174 placed on file on 02-DEC-2013

Affidavit of service of Darlene Power sworn on 02-DEC-2013 on behalf of Apotex confirming service of Doc. NO. 174 upon all parties by courier on 02-DEC-2013 filed on 02-DEC-2013

Affidavit of service of Darlene Power sworn on 28-NOV-2013 on behalf of Apotex confirming service of Doc. no. 173 upon all parties by courier on 28-NOV-2013 filed on 28-NOV-2013

Book of Authorities consisting of 1 volume(s) on behalf of Pharmascience Inc & Apotex received on 28-NOV-2013

Sealed envelope pursuant to Order Prothonotary Aronovitch 7-DEC-09 on behalf of Apotex and Pharmascience Inc. purporting to contain Written Representations of Apotex and Pharmascience Inc (Re: GSK Motion to Amend) Filed on 02-DEC-2013

Sealed envelope pursuant to Order Prothonotary Aronovitch 7-DEC-09 on behalf of Plaintiff purporting to contain Responding Motion Reocrd (Re: GSK Motion to Amend) Filed on 28-NOV-2013

Letter from Plaintiff dated 28-NOV-2013 outlining the documents to be used at the 4-DEC-2013 hearing (electronic) received on 28-NOV-2013

Acknowledgment of Receipt received from all parties (Goodmans by phone only) with respect to the Direction of the Court dated 17-Dec-2013 placed on file on 18-DEC-2013

Writ of Subpoena Ad Testificandum TO: Lucie Robitaille, Chair of Board and CEO, Management Board of Parental Insurance issued on 20-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 20-DEC-2013 Tariff any other proceeding - $30.00

Solicitor's certificate of service on behalf of Jesse Todres confirming service of Doc 169 upon all parties by overnight courier on 17-DEC-2013 filed on 18-DEC-2013

Motion Record containing the following original document(s): 166 167 168 Number of copies received: 3 on behalf of Glaxosmithkline Inc filed on 18-DEC-2013

Written Representations contained within a Motion Record on behalf of Glaxosmithkline Inc. concerning Motion in writing Doc. No. 166 filed on 18-DEC-2013

Consent on behalf of all parties to the Orders in the form attached as Schedules A, B and C; Doc 166 filed on 18-DEC-2013

Notice of Motion contained within a Motion Record on behalf of GlaxoSmithKline Inc et al. in writing (on consent) for An Order varying the Protective Order in Court file T-14-09; An Order varying the Further Amended Protective Order and Confidentiality Order pursuant to R.151 in Court file T-2109-09; An Order varying the Amended Confidentiality and Protective Order pursuant to R.151 in Court file T-643-10; such further and other relief filed on 18-DEC-2013 Draft Order\\Judgment received.

Covering letter from GSK dated 12-DEC-2013 concerning Doc. Nos. 148 151 154 157 159 placed on file on 13-DEC-2013

Covering letter from PMS in T-2101-09 dated 10-DEC-2013 concerning Doc. Nos. 138 141 145 placed on file on 11-DEC-2013

Written directions received from the Court: The Honourable Mr. Justice Manson dated 17-DEC-2013 directing that 1. Apotex and Pharmascience shall file copies of six of eight expert reports, two reports of which will be in redacted form, in Ottawa by Wednesday, December 11, 2013; 2. GSK shall file copies of its current expert reports in Ottawa no later than Friday, December 13, 2013, including those validity expert reports requiring redactions in respect of the issue no longer proceeding to trial; 3. Counsel are to confer by Friday, December 13, 2013 in regards to changes to the trial schedule due to particular evidence no longer being led; 4. GSK shall provide updated reports from its accounting expert in respect of infringement damages to counsel for Apotex and Pharmascience for their consideration; 5. In the event Apotex or Pharmascience take issue with any of the updates to GSK's accounting expert's infringement damages reports, the Parties can write to the Court and request a Case Management Conference to address this issue; and 6. With respect to the expert reports previously filed and to the extend that only one copy was filed, the parties are to submit a second copy for the file, by January 2, 2014 placed on file on 17-DEC-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 17-DEC-2013 directing that having considered the submissions of counsel concerning my direction on December 10, 2013, paragraph 4 of the draft Direction submitted to the Court on December 13, 2013 should be deleted. While the acknowledgment by GlaxoSmithKline Inc. et al (GSK) that the third party reports ordered produced are not privileged does not act as a waiver of priviledge in respect of any other documents or information not contained in the reports, the direction does not need to, nor should it, extend to any such hypothetical documents or information not in issue placed on file on 17-DEC-2013 Confirmed in writing to the party(ies)

Writ of Subpoena Ad Testificandum LUCIE ROBITAILLE, VICE PRESIDENT, INSTITUT NATIONAL d' EXCELLENCE SANTE ET EN SERVICES SOCIAUX, 2535 BOULEVARD LAURIER, 5TH FLOOR, QUEBEC GIV 4M3, QC issued on 17-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 17-DEC-2013 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum directed to VIRGINIA CIROCCO-1820 SHADY CREEK COURT. MISSISSAUGA, ON. L5L 3W2. issued on 17-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 17-DEC-2013 Tariff any other proceeding - $30.00

Letter from counsel for PMS in T-643-10 dated 16-DEC-2013 providing submissions in response to GSK's re: why par. 4 should not be included in the direction arising out of the CMC held 10-Dec-2013 received on 16-DEC-2013

Letter from GSK dated 13-DEC-2013 providing a draft direction arising out of the CMC held on 10-Dec-2013 and submissions supporting their position with regards to par. 4 of the draft direction received on 13-DEC-2013

Writ of Subpoena Ad Testificandum BRENT FRASER, DIRECTOR, DRUG PROGRAM SERVICES, ONTARIO PUBLIC DRUG PROGRAM BUREAU, HEPBURN BLOCK, 9TH FLOOR, 80 GROSVENOR ST. TORONTO, ON, M7A 1R3 issued on 16-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 16-DEC-2013 Tariff any other proceeding - $30.00

Letter from Plaintiff dated 16-DEC-2013 re: expert reports dealing with section 8. cc to all parties received on 16-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Dr. Hans Maag dated 18-Oct-2013 (Vol 1 and 2 of 2)(see annex I for Vol 2) and doc. 158.(Only two copies were filed and one sent directly to the Trial Judge) Filed on 13-DEC-2013

Certificate of Solicitor Jordana Sanft attaching thereto the proposed evidence of expert witness of Dr. Hans Maag on behalf of Defendant filed on 13-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Dr. Stephen Graham Davies dated 22-May-2013 and doc. 156 (only 2 copies filed and 1 sent directly to trial judge) Filed on 13-DEC-2013

Certificate of Solicitor Jordana Sanft attaching thereto the proposed evidence of expert witness Dr. Stephen Graham Davies on behalf of Plaintiffs filed on 13-DEC-2013

Vol 2 of 2 of the Expert Report of Dr. Jennifer B. Dressman dated 20-Oct- 2013 (part of doc. 154 for not sealed)(only 2 copies filed and 1 sent directly to trial judge) filed on 13-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Dr. Jennifer B. Dressman dated 20-Oct-2013 (vol 1 of 2) and doc. 153 (only 2 copies filed and 1 sent directly to the trial judge) Filed on 13-DEC-2013

Certificate of Solicitor Jordana Sanft attaching thereto the proposed evidence of expert witness Dr. Jennifer B. Dressman on behalf of Defendant filed on 13-DEC-2013

Vol 2 of 2 of the Expert Report of Dr. Stephen Graham Davies (part of doc 151 but not sealed)(2 copies only filed and 1 sent directly to the trial judge) filed on 13-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Dr. Stephen Graham Davies dated 20-Oct-2013 (vol 1 of 2) and doc. 150 (only 2 copies received and 1 sent directly to the trial judge) Filed on 13-DEC-2013

Certificate of Solicitor Jordana Sanft attaching thereto the proposed evidence of expert witness Dr. Stephen Graham Davies dated 20-Oct-2013 on behalf of Defendant filed on 13-DEC-2013

Vol 2 of 2 of the Expert Report of Dr. William R. Greco dated 16-Oct-2013 (part of doc 148 but not sealed)(only 2 copies filed and 1 sent directly to trial judge) filed on 13-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Dr. William R. Greco dated 16-Oct-2013 (vol 1 of 2) and doc. 147 (only two copies filed and 1 sent directly to the trial judge) Filed on 13-DEC-2013

Certificate of Solicitor Jordana Sanft attaching thereto the proposed evidence of expert witness Dr. William R. Greco on behalf of Defendant filed on 13-DEC-2013

Schedule A of the Expert Report of Dr. Stephen Hanessian dated 22-May-2013 (only one copy filed and sent directly to the trial judge) filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of counsel for PMS in T-2101-09 purporting to contain the Expert Report of Dr. Stephen Hanessian dated 22-May-2013 and doc 144 (only 2 copies filed and 1 sent directly to trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Carol Hitchman attaching thereto the proposed evidence of expert witness Dr. Stephen Hanessian dated 22-May-2013 on behalf of counsel for PMS in T-2101-09 filed on 11-DEC-2013

Schedule A (2 vols) and B (2 vols) of the Expert Report of Dr. Jonathan Dordick dated 21-May-2013 (only 2 copies filed and 1 sent directly to the trial judge) filed on 11-DEC-2013

Writ of Subpoena Ad Testificandum issued on 13-DEC-2013 cc filed

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of counsel for PMS in T-2101-09 purporting to contain the Expert Report of Dr. Jonathan Dordick dated 21-May-2013 and doc. 139 (only 2 copies filed and 1 sent directly to the trial judge) Filed on 11-DEC-2013

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 13-DEC-2013 Tariff any other proceeding - $30.00

Certificate of Solicitor Carol Hitchman attaching thereto the proposed evidence of expert witness Dr. Jonathan S. Dordick dated 21-May-2013 on behalf of counsel for PMS in T-2101-09 filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of counsel for PMS in T-2101-09 purporting to contain the Expert Report of Dr. Stephen Hanessian dated 16-Oct-2013 and doc. 137 (only 2 copies filed and 1 sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Alisse Houweling attaching thereto the proposed evidence of expert witness Dr. Stephen Hanessian dated 16-Oct-2013 on behalf of the Defendants filed on 11-DEC-2013

Covering letter from Defendant dated 10-DEC-2013 concerning Doc. Nos. 127 129 131 133 135 placed on file on 11-DEC-2013

****** CANCELLED ****** Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness Andrew Tepperman on behalf of Defendant filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Neil Palmer dated 20-Oct-2013 and doc. 134 (only two copies were filed and one sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness of Neil Palmer dated 20-Oct-2013 on behalf of Defendant filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Ross Hamilton dated 21-Oct-2013 and doc. 132(only two copies filed and one sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness Ross Hamilton on behalf of Defendant filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Dr. Iain Cockburn dated 3-Dec-2013 and doc 130 (only two copies filed and one sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness Iain Cockburn on behalf of Defendant filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Mr. Ross Hamilton dated 22-May-2013 and doc. 128 (Only two copies filed and one sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Jane E. Caskey attaching thereto the proposed evidence of expert witness Mr. Ross Hamilton on behalf of Defendant filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Defendant purporting to contain the Expert Report of Dr. Barbara Romanowski (Vol 1 and 2 of 2) dated 19-Oct- 2013 and doc 126 (only two copies were filed and one sent directly to the Trial Judge) Filed on 11-DEC-2013

Certificate of Solicitor Jordana Sanft attaching thereto the proposed evidence of expert witness of Dr. Barbara Romanowski on behalf of Defendant filed on 11-DEC-2013

Certificate of Solicitor Jenene Roberts attaching thereto the proposed evidence of expert witness Dr. Robert S. Langer on behalf of Plaintiff filed on 11-DEC-2013

Certificate of Solicitor Jenene Roberts attaching thereto the proposed evidence of expert witness Dr. Clyde S. Crumpacker II on behalf of Plaintiff filed on 11-DEC-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Nov-2013 placed on file on 28-NOV-2013

Covering letter from Apotex dated 10-DEC-2013 concerning Doc. Nos. 122 123 placed on file on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Apotex purporting to contain the expert report of Dr. Robert S. Langer (only 2 copies filed and one sent directly to the trial judge.) Filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 7-Dec-2009 on behalf of Apotex purporting to contain the expert report of Dr. Clyde S. Crumpacker II and doc. 124 (only 2 copies filed and one sent directly to the trial judge) Filed on 11-DEC-2013

Ottawa 10-DEC-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the issues with the filing of expert reports and privilege issues and correspondance dated 2-Dec-2013 from GSK Result of Hearing: Direction to follow held in chambers by way of Conference Call Duration per day: 10-DEC-2013 from 12:30 to 12:48 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Harry Radomski, Jerry Topolski and Dave Scrimger 416-597-4142 representing Apotex Jordana Sanft, Jane Caskey, Patrick Kierans and Amy Grenon 416-216-4798 representing GSK Carol Hitchman and Alisse Houweling 416-859-2722/416-865-4010 representing Pharmascience in T-2101-09 and T-643-10 Draft Decision to be submitted by counsel for GSK Minutes of Hearing entered in Vol. 893 page(s) 94 - 96 Abstract of Hearing placed on file

Covering letter from GSK dated 29-NOV-2013 concerning Doc. No. 120 placed on file on 29-NOV-2013

Solicitor's certificate of service on behalf of Daniel Daniele confirming service of doc. 120 upon all parties by telecopier on 29-NOV-2013 filed on 29-NOV-2013

GSK's Patent Claims Chart filed on 29-NOV-2013

Claims Chart of Apotex Inc. and Pharmascience Inc. et al. (cc'd to counsel for GSK and counsel for PMS in T-2101-09) filed on 29-NOV-2013

Letter from GSK dated 03-DEC-2013 advising that Apotex intends to dispute the propriety of the redactions to the third party economic studies at the hearing of the motion to amend on 4-Dec-2013,asking that the Court not entertain Apotex's request until proper motion is filed and asking that a schedule for filing of material and hearing date be set received on 03-DEC-2013

Acknowledgment of Receipt received from all parties with respect to the Order dated 6-Dec-2013 placed on file on 06-DEC-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 06-DEC-2013 directing that a case management conference by telephone conference is scheduled to take place on Tuesday December 10, 2013 at 12:30 EST placed on file on 06-DEC-2013 Confirmed in writing to the party(ies)

Order dated 06-DEC-2013 rendered by The Honourable Mr. Justice Manson Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 93 Result: dismissed Filed on 06-DEC-2013 certified copies sent to parties entered in J. & O. Book, volume 1213 page(s) 150 - 161 Interlocutory Decision

Letter from GSK dated 06-DEC-2013 requesting a CMC to discuss issues with filing of expert reports and attaching correspondence between the parties on the subject (sent to Justice Manson by e-mail on 6-Dec-2013) received on 06-DEC-2013

Vancouver 04-DEC-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion Doc. No. 93 on behalf of Defendant/Plts by Counterclaim Result of Hearing: Matter reserved held in Court Senior Usher: Heather Richards Duration per day: 04-DEC-2013 from 09:10 to 11:35 Courtroom : Courtroom No. 601 - Vancouver Court Registrar: Sandra McPherson Total Duration: 2h25min Appearances: Ms Allyson Whyte-Nowak (Norton Rose Canada LLP) 1.416.216.1899 representing Plaintiff Glaxosmithkline, Inc. H.B.Radomski/Jerry Topolski (Goodmans LLP) 1.416.979.2211 representing Plaintiff Warren Sprigings/Christopher Tan (Sprigings IP) 1.416.777.0888 representing Defendant Documents filed at hearing: 115 116 117 Court Reporter: Sharon Leeburn, All-West Court Reporters Vancouver BC 604.683.4774 04-DEC-2013 Transcript not requested Minutes of Hearing entered in Vol. 892 page(s) 353 - 357 Abstract of Hearing placed on file

Transcript of cross-examination held on 29-NOV-2013 RE: Affidavit of Doug Welsh filed at hearing on 04-DEC-2013

Transcript of cross-examination held on 28-NOV-2013 RE: Affidavit of Andrew C. Harington filed at hearing on 04-DEC-2013

Transcript of cross-examination held on 28-NOV-2013 RE: Affidavit of Howard Rosen filed at hearing on 04-DEC-2013

Letter from Apotex dated 02-DEC-2013 in response to GSK's letter dated 2-Dec-2013 (sent to Manson J. by e-mail on 3-Dec-2013) received on 02-DEC-2013

Letter from GSK dated 02-DEC-2013 providing an update on the issue of privilege and requesting that the Court issue a direction in advance of GSK producing the documents (sent to Manson J. by e-mail on 3-Dec-2013) received on 02-DEC-2013

Copy of Notice of Appeal (Appeal Court File No. A-398-13 ) appealing the Order of Manson J. dated 26-Nov-2013 filed in the Court of Appeal on 27-NOV-2013 on behalf of Apotex placed on file on 28-NOV-2013

Letter from Apotex dated 27-NOV-2013 advising that Apotex and PMS can confirm that they are able to provide 5 expert reports at this time (sent to Manson J. by e-mail on 28-Nov-2013) received on 27-NOV-2013

Letter from Plaintiff dated 22-NOV-2013 attaching its trial chart received on 22-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 27-NOV-2013 directing that if the parties cannot agree on production of the transfer pricing documents by GSK for the years 2005 through 2008, by Friday November 29, 2013, GSK will forward a brief with sufficient particulars to opposing counsel and to the Court, specifying the origin and recipient of each document for which solicitor-client privilege is claimed and the reason for the claim of privilege for each such document. GSK will also supply a copy of each such document, under seal, to the Court only. GSk is to file the brief and documents, in Vancouver, to my attention, no later than noon on December 2, 2013. Counsel for Apotex and PMS shall have until 4:30 pm EST on December 3, 2013, to serve and file any responding brief to GSK's brief, and the matter will be heard by me on December 4, 2013, in Vancouver placed on file on 27-NOV-2013 Confirmed in writing to the party(ies)

Ottawa 27-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss privilege issues raised in GSK's correspondence dated 26-Nov-2013 Result of Hearing: GSK will serve and file a brief of documents and submissions in Vancouver by 29-Nov-2013. Apotex and PMS will file responding brief and/or submissions by 4:30 p.m. 2-Dec-2013 and the Court will hear the parties on this issue on 4-Dec-2013 held in chambers by way of Conference Call Duration per day: 27-NOV-2013 from 02:30 to 02:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 10min Appearances: Jerry Topolski 416-597-5907 representing Apotex Jane Caskey and Dan Daniele 416-216-2317 representing GSK Christopher Tan 416-777-2647 representing PMS Minutes of Hearing entered in Vol. 892 page(s) 46 - 47 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the Order of the Court dated 26-Nov-2013 placed on file on 26-NOV-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 21-Nov-2013 placed on file on 21-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 26-NOV-2013 directing that a case management conference by telephone conference will take place on November 27, 2013 at 2:30 p.m. (to discuss issues raised in GSK's letter dated 26-Nov-2013) placed on file on 26-NOV-2013 Confirmed in writing to the party(ies)

Order dated 26-NOV-2013 rendered by The Honourable Mr. Justice Manson Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 98 Result: granted in part Filed on 26-NOV-2013 copies sent to parties entered in J. & O. Book, volume 1211 page(s) 292 - 296 Interlocutory Decision

Letter from GSK dated 26-NOV-2013 seeking a direction of the Court relating to an issue of privilege (sent to Mr. Justice Manson by e-mail on 26-Nov-2013) received on 26-NOV-2013

Draft Order concerning Motion Doc. No. 98 consented to by all parties received on 25-NOV-2013

Solicitor's certificate of service on behalf of Daniel Danielle confirming service of Doc. No. 112 upon Plaintiff by personal service on 22-NOV-2013 filed on 22-NOV-2013

Trial Chart on behalf of the Defendant filed on 22-NOV-2013

Letter from Pharmascience in T-643-10 dated 22-NOV-2013 attaching a draft order re: motion doc. 98 not consented to by GSK received on 22-NOV-2013

Ottawa 21-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the direction of the Court dated 19-Nov-2013 which requires the parties to file the expert reports Result of Hearing: The Court asked for a report by November 29th on what report will be available to the Court when and the reports the parties are sure to rely on would be filed by December 6, 2013. The parties are therefore relieved from having to comply with the November 19th direction held in chambers by way of Conference Call Duration per day: 21-NOV-2013 from 03:30 to 04:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jerry Topolski and Harry Radomski 416-597-5907 representing Apotex Patrick Kierans, Jordanna Sanft, Daniel Daniele and Amy Grenon 416-216-2317 representing GSK Carol Hitchman and Alisse Howeling 416-865-8259 representing Pharmascience in T-2101-09 Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Minutes of Hearing entered in Vol. 891 page(s) 406 - 409 Abstract of Hearing placed on file

****** CANCELLED ****** Ottawa 21-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the Court's direction dated 19-Nov-2013 requiring the expert reports to be filed Result of Hearing: The Court asked for a report by November 29th on what report will be available when and the reports the parties are sure to rely on would be filed by December 6, 2013. The parties are therefore relieved from having to comply with the November 19th direction held in chambers by way of Conference Call Duration per day: 21-NOV-2013 from 03:30 to 04:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jerry Topolski 416-597-5907 representing Apotex Patrick Kierans, Jordanna Sanft, Daniel Daniele and Amy Grenon 416-216-2317 representing GSK Carol Hitchman and Alisse Howling 416-865-8259 representing Pharmascience in T-2101-09 Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Minutes of Hearing entered in Vol. 891 page(s) 402 - 405 Abstract of Hearing placed on file

Affidavit of service of JOHANNA PALACIOS sworn on 22-NOV-2013 on behalf of Plaintiff confirming service of DOC 110 upon DEFENDANT AND PLAINTIFFS BY COUNTERCLAIM, GLAXOSMITHKLINE INC. ET AL by courier on 22-NOV-2013 filed on 22-NOV-2013

Trial Record on behalf of Plaintiff filed on 22-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 21-NOV-2013 directing that GSK's motion to amend will be heard in Vancouver on December 4, 2013 at 9:00 a.m. for 1 day. Apotex's and PMS' responding motion record including transcripts of cross-examinations but without written argument will be served and filed, in Vancouver, by noon, on December 2, 2013. Apotex's and PMS' responding written argument will be served and filed electronically at cmt_ottawa@cas-satj.gc.ca by December 2, 2013 placed on file on 21-NOV-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 20-NOV-2013 indicating that the parties are available for the hearing of GSK's motion to amend on December 4, 2013 at 9:00 a.m. in Vancouver and proposing a schedule for the filing of responding documents received on 21-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 20-NOV-2013 directing that a case management telephone conference will take place on November 21, 2013 at 3:30 p.m. placed on file on 20-NOV-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 19-NOV-2013 directing that any expert report in chief and in rebuttal served between the parties to date shall be submitted for filing with the Court by November 27th. Any expert report which is due to be served prior to trial shall be submitted for filing with the Court on the date it is due to be served placed on file on 19-NOV-2013

Letter from Apotex dated 20-NOV-2013 requesting a CMC with Manson J. to discuss certain issues in relation to the Direction dated 19-Nov-2013 received on 20-NOV-2013

Toronto 12-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion Doc. No. 98 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Joe Mischuk Duration per day: 12-NOV-2013 from 09:35 to 15:31 Courtroom : Courtroom No. 4-B - Toronto Court Registrar: Heather Michaud Total Duration: 5h 56min Appearances: Kenneth Crofoot 416-597-4110 representing Plaintiff Jane E. Caskey 416-216-1899 representing Defendant Amy Grenon 416-216-1931 representing Defendant Draft Decision to be submitted by the parties Comments: LAPTOP Z006122 was used to record this hearing. Heard together with T-2101-09 and T-643-10. Minutes of Hearing entered in Vol. 890 page(s) 239 - 255 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dates 5-Nov-2013 placed on file on 05-NOV-2013

Acknowledgment of Receipt received from all parties with respect to Order doc. no. 109 placed on file on 08-NOV-2013

Order dated 08-NOV-2013 rendered by The Honourable Mr. Justice Manson Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: an extensive timetable is set. See Order for details Filed on 08-NOV-2013 copies sent to parties entered in J. & O. Book, volume 1209 page(s) 424 - 431 Interlocutory Decision

Solicitor's certificate of service on behalf of Christopher Tan confirming service of Doc. 98, Document Brief and Book of Authorities upon all parties by personal service on 08-NOV-2013 filed on 08-NOV-2013

Solicitor's certificate of service on behalf of Amy Grenon confirming service of Doc. 104, Transcript Brief and Book of Authorities upon all parties by personal service on 08-NOV-2013 filed on 08-NOV-2013

Covering letter from GSK dated 08-NOV-2013 concerning Doc. No. 104 placed on file on 08-NOV-2013

Affidavit of of Norman Vojir sworn on 11-NOV-2013 on behalf of GSK in opposition to Motion Doc. No. 98 filed on 12-NOV-2013

Book of Authorities consisting of 2 volume(s) on behalf of GSK received on 08-NOV-2013 Sent directly to Presiding Judge

Sealed envelope pursuant to Order of 7-Dec-2009 on behalf of GSK purporting to contain 3 volumes of a Transcript Brief Filed on 08-NOV-2013

Motion Record in response to Motion Doc. No. 98 containing the following original document(s): 100 101 102 103 Number of copies received: 3 on behalf of GSK (responding chart is at Tab A of Vol 4 of 4 of motion record) filed on 08-NOV-2013

Written Submissions on behalf of GSK concerning Motion Doc. No. 98 filed on 08-NOV-2013

Sealed envelope pursuant to Order dated 7-Dec-2009 on behalf of GSK purporting to contain the affidavit of Christine Ingham and its exhibits A and B sworn on 8-Nov- 2013 Filed on 08-NOV-2013

Affidavit of Cindy Roll sworn on 08-NOV-2013 contained within a Motion Record on behalf of GSK in opposition to Motion Doc. No. 98 filed on 08-NOV-2013

Affidavit of Normand Vojir (not sworn yet) received on 08-NOV-2013

Sealed envelope pursuant to Order of 7-Dec-2009 on behalf of GSK purporting to contain the affidavit of Christine Ingham and exhibits A to T Filed on 08-NOV-2013

Book of Authorities consisting of 1 volume(s) on behalf of Apotex and Pharmascience Inc. et al received on 08-NOV-2013 Sent directly to Presiding Judge

Sealed envelope purporting to contain the Document Brief of Apotex and Pharmascience Inc. et al. submitted in support of motion doc. 98 filed on 08-NOV-2013

Sealed envelope containing a Notice of Motion on behalf of Apotex and Pharmascience Inc. et al. returnable at Special Sitting in Toronto on 12-NOV-2013 to begin at 09:30 for an Order compelling the representatives of the Responding Parties, GlaxoSmithKline Inc....to provide answers to the questions undertaken to be answered from the written questions of Pharmascience and Apotex by November 15, 2013... filed on 08-NOV-2013

Solicitor's certificate of service on behalf of Amy Grenon confirming service of Doc. 96 and Book of Authorities upon Apotex Inc. by personal service on 05-NOV-2013 filed on 05-NOV-2013

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 05-NOV-2013

Motion Record containing the following original document(s): 93 94 95 Number of copies received: 3 on behalf of Defendant filed on 05-NOV-2013

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 93 filed on 05-NOV-2013

Affidavit of Norman Vojir sworn on 05-NOV-2013 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 93 with Exhibits A (confidential) filed on 05-NOV-2013

Notice of Motion contained within a Motion Record on behalf of Defendant returnable (but no hearing date indicated at this time) for an Order permitting GSK to serve and file the Second Further Amended Statement of Defense and Counterclaim, the Third Further Amended Statement of Claim, adding GlaxoSmithKline Intellectual Property (no. 2) Limited as Plaintiff by Counterclaim in file T-14-09 and as Plaintiff in file T-2101-09, and amending the style of cause. filed on 05-NOV-2013

Draft Order concerning outcome of CMC held on 11-Oct-2013 & amalgamation of existing timetables consented to by all parties (sent to the CMJ on 5-Nov-2013) received on 05-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 05-NOV-2013 directing that by November 6, 2013, the parties are to provide the draft order regarding the outcome of the case management conference held on October 11, 2013, which was agreed would include all outstanding timelines set by previous Orders or, by the same date, provide their availability on November 7 and 8 for a case management conference to discuss the issues preventing the parties from producing the draft order placed on file on 05-NOV-2013 Confirmed in writing to the party(ies)

Writ of Subpoena Ad Testificandum issued on 04-NOV-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 04-NOV-2013 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 04-NOV-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 04-NOV-2013 Tariff any other proceeding - $30.00

Letter from GSK dated 21-OCT-2013 advising that they need a few more days to provide a draft order re: the CMC of 11-Oct-2013 received on 21-OCT-2013

Letter from GSK dated 18-OCT-2013 advising that they need until 21-Oct-2013 to provide a draft order re: the CMC of 11-Oct-2013 received on 18-OCT-2013

Ottawa 11-OCT-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss amendments to schedule Result of Hearing: the parties will provide a draft order which will set out all remaining timelines including timelines set by previous orders by next week held in chambers by way of Conference Call Duration per day: 11-OCT-2013 from 11:30 to 12:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Apotex Jordana Sanft and Jane Caskey 416-216-4000 representing GSK Carol Hitchman 416-865-8259 representing Pharmascience in T-2101-09 Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Comments: November 12, 2013 has been set aside for the hearing of refusals motions re: third round discovery Minutes of Hearing entered in Vol. 888 page(s) 375 - 376 Abstract of Hearing placed on file

Letter from Apotex dated 10-OCT-2013 providing a proposed schedule to be discussed at the CMC on 11-Oct-2013 (sent to CMJ on 11-Oct-2013) received on 11-OCT-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 08-OCT-2013 directing that a case management conference by telephone conference will take place on October 11, 2013 at 11:30 a.m. to discuss amendments to the timetable placed on file on 08-OCT-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 09-OCT-2013 advising that the parties are discussing alternative dates for the discovery of GSK's discovery representative (brought to the CMJ's attention on 10-Oct-2013) received on 10-OCT-2013

Ottawa 08-OCT-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the scope of the third round discovery Result of Hearing: See abstract in T-2101-09 held in Court Senior Usher: S. Young Duration per day: 08-OCT-2013 from 09:30 to 11:55 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 2h30min Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Apotex Patrick Kierans and Jane Caskey 416-216-4000 representing GSK Warren Sprigings and Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Minutes of Hearing entered in Vol. 888 page(s) 322 - 323 Abstract of Hearing placed on file

Memorandum to file from Julie Dulac dated 08-OCT-2013 Briefs were filed by the parties for the purpose of the in person case management conference scheduled on 8-Oct-2013. Only one copy of the briefs was provided. They were filed in T-2101-09 only placed on file.

Letter from GSK dated 07-OCT-2013 providing a status report received on 08-OCT-2013

Acknowledgment of Receipt received from both parties with respect to the instructions of the Court dated 2-Oct-2013 placed on file on 02-OCT-2013

Letter from Plaintiff dated 03-OCT-2013 advising that they assume that since there was already a trial management conference and another trial management conference is scheduled on 8-Oct- 2013 in these matters, the requirement in par 1(e) of the April 24, 2013 Order is no longer required. (I e-mailed the parties and advised that Mr. Topolski's assumption is correct; no need for a request for a TMC) received on 03-OCT-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 02-OCT-2013 directing that (further to Apotex's correspondence dated 1-Oct-2013) the proposed timetable is fine, but two notes: final arguments must be finished by March 20; if this is an issue, we will have to start earlier; otherwise, if counsel are agreed, we'll reserve the January 10th date as the start date. Counsel are to confirm agreement and a direction will issue accordingly placed on file on 02-OCT-2013 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 01-OCT-2013 advising the Trial Judge that the parties reached a resolution with respect to the order of presentation of the various issues raised in the actions and the timing of the trial (sent to the Trial Judge electronically on 2-Oct-2013 received on 01-OCT-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 01-Oct-2013 placed on file on 01-OCT-2013

Copy of written direction dated 01-OCT-2013 rendered by The Honourable Mr. Justice Manson placed on file. Original filed on Court File No. T-2101-09

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 27-Sep-2013 placed on file on 27-SEP-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 27-SEP-2013 directing that GSK's request that the third round discovery scheduled to take place on October 2 and 3, 2013 and the case management conference scheduled September 30th be adjourned is granted. The fact that there are some 4000 questions raised in what is supposed to be a limited third round of discovery is unacceptable. Proportionality is completely missing. I direct that Pharmascience and Apotex reconsider and limit the questions to be answered. By 5:00 p.m. September 30, 2013, parties will advise when the re-attendance for discovery can be held during the week of October 14, 2013. By the same date, the parties will provide their availability for an in person case management conference, in Ottawa, during the week of October 7, 2013 (except October 10, 2013) placed on file on 27-SEP-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 27-SEP-2013 requesting a direction adjourning the discoveries scheduled on October 2 and 3, 2013 and the CMC scheduled on 30-Sep-2013 to be set down as an in person hearing with the necessary productions and documents in front of the Court received on 27-SEP-2013

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 25-Sep-2013 placed on file on 25-SEP-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 25-SEP-2013 directing that a case management teleconference is scheduled to take place on September 30, 2013 at 10:00 a.m. to discuss the issues raised in the parties' correspondence dated September 23 and 24, 2013 placed on file on 25-SEP-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 25-SEP-2013 re: the parties correspondence dated September 23 and 24, 2013

Letter from Pharmascience (on behalf of Apotex) dated 24-SEP-2013 submitting that a CMC to discuss discovery issues is premature at this time received on 24-SEP-2013

Letter from GSK dated 23-SEP-2013 advising the Court of issues with respect to further examination for discovery and requesting a CMC to address these issues in advance of the examinations for discovery received on 23-SEP-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 18-Sep-2013 placed on file on 20-SEP-2013

Written directions received from the Court: The Honourable Mr. Justice Manson dated 18-SEP-2013 directing that 1. All parties will serve and file their amended pleadings by September 6, 2013; 2. Counsel for Pharmascience et al. and Apotex will deliver to counsel for GSK et al. questions that will be asked of Mr. Vojir by September 19, 2013; 3. Counsel for GSK et al. will make Mr. Vojir available to be examined for 2 days during the week of September 30, 2013, subject to his availability. 4. All parties will serve and file trial charts by November 8, 2013; 5. All parties will serve and file claims charts by November 29, 2013; and 6. The Court has reserved on the issue of the order of trial issues until after the filing of the trial chart, and will issue an order regarding this matter during the week of November 11, 2013 placed on file on 18-SEP-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 16-SEP-2013 re: (to Manson J. by e-mail)the draft direction and minutes of trial management conference

Minutes of Trial Management Conference received on 13-SEP-2013

Draft Direction concerning Trial Management Conference received on 13-SEP-2013

Solicitor's certificate of service on behalf of Amy E. Grenon confirming service of Doc 87 upon Plaintiff by telecopier on 06-SEP-2013 filed on 06-SEP-2013

Reply to Defence to Counterclaim on behalf of Defendant Filed on 06-SEP-2013

Affidavit of service of PEARL PATTERSON sworn on 05-SEP-2013 on behalf of Plaintiff confirming service of DOC 85 upon all parties by courier on 05-SEP-2013 filed on 05-SEP-2013

Amended (THIRD AMENDED) REPLY and Defence to Counterclaim on behalf of Plaintiff Filed on 05-SEP-2013

Toronto 03-SEP-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Trial Management Conference Result of Hearing: On consent of counsel for the parties, the Court determines the following steps to be complete: 1. Further Amended Pleadings shall be served and filed by September 6/13. 2. Apotex and Pharmascience shall deliver their questions for discovery to Glaxosmithkline by September 19/13. 3. The cross-examinations of the GSK representative shall be conducted during the week of September 30/13. 4. Each party shall file a Trial schedule by November 8/13. 5. Claim Charts shall be filed by November 29/13. held ADR Senior Usher: Anne Brzuchalski Duration per day: 03-SEP-2013 from 03:00 to 04:00 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Mary Sansone Total Duration: 1h Appearances: Harry Radomski, David Scrimger, Jerry Topolski 416 979-2211 representing Plaintiff Patrick Kierans, Jane Caskey, Jordana Sanft 416 216-4000 representing Defendant Comments: Heard jointly together with T-2101-09 and T-643-10. See T-14-09 for the full minutes of hearing. Minutes of Hearing entered in Vol. 885 page(s) 457 - 459 Abstract of Hearing placed on file

Acknowledgment of Receipt received from GSK and PMS with respect to Madam Aronovitch's direction dated 21-Aug-2013 placed on file on 21-AUG-2013

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 21-AUG-2013 directing that the continuation of the mediation scheduled November 18-21 has been rescheduled to November 13-15. placed on file on 21-AUG-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 21-AUG-2013 directing that as there is no agreement between the parties and a Direction has not issued, parties are to refer the matters in dispute to Justice Manson. The contentious issues could only be dealt with by Direction, if with the guidance I provided, parties were able to come to some agreement. Failing, agreement, the disputes will likely require a motion placed on file on 21-AUG-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 20-AUG-2013 advising that the parties are unable to come to an agreement re: oral direction given by Madam Aronovitch at the CMC August 6, 2013 (sent to Madam Aronovitch on 21-Aug-2013) received on 21-AUG-2013

Memorandum to file from Julie Dulac dated 16-AUG-2013 the parties were advised that they may submit their proposed timetable by 20-Aug-2013 placed on file.

Letter from GSK dated 15-AUG-2013 requesting until August 20th to submit a schedule for service and filing of the amended pleadings and written discovery received on 15-AUG-2013

Acknowledgment of Receipt received from all parties with respect to the direction of Manson J. dated 9-Aug-2013 placed on file on 09-AUG-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 09-AUG-2013 directing that a CMC/Trial Management Conference is scheduled, in person, in Toronto on September 3, 2013 at 3:00 p.m. placed on file on 09-AUG-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 09-AUG-2013 re: (Manson J. by e-mail) GSK's letter dated 8-Aug-2013

Letter from GSK dated 08-AUG-2013 providing the parties' availability for a CMC/trial management conference in Toronto in person or by VC with Mr. Justice Manson received on 08-AUG-2013

Ottawa 06-AUG-2013 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Parties will provide their availability for a CMC/trial management conference with Manson J. by August 8, 2013. By August 15th they will provide a draft order re: amended timetable held in chambers by way of Conference Call Duration per day: 06-AUG-2013 from 11:00 to 11:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: David Scrimger and Jenene Roberts 416-597-6262 representing Apotex Jordana Sanft 416-317-4613 representing GSK Jane Caskey 416-458-9840 representing GSK Daniel Daniele 416-216-2317 representing GSK Carol Hitchman and Alisse Houweling 416-865-8259 representing PMS in T-2101-09 Christopher Tan and Warren Sprigings 416-777-2647 representing PMS in T-643-10 Minutes of Hearing entered in Vol. 884 page(s) 470 - 472 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 02-AUG-2013 re: Preparation of the file for the case conference on August 6, 2013

Letter from GlaxoSmithKline dated 02-AUG-2013 in response to the letter from Mr. Tan dated July 29, 2013 received on 02-AUG-2013

Letter from Pharmascience dated 01-AUG-2013 providing the Court with a status report received on 01-AUG-2013

Letter from Pharmascience dated 29-JUL-2013 requesting that the issues in the letter be discussed at the case conference on August 6, 2013 received on 29-JUL-2013

Letter from Defendant dated 31-JUL-2013 providing the court with dates of availability to continue the mediation received on 31-JUL-2013

Oral directions received from the Court: Chief Justice Crampton dated 29-JUL-2013 directing that Madam Prothonotary Aronovitch will be on sabbatical from August 16, 2013 to December 30, 2013. In her absence, Mr. Justice Manson is hereby assigned as case management judge in respect to the above noted file. Parties are to continue to send draft orders, directions and correspondence to cmt_ottawa@cas-satj.gc.ca. placed on file on 29-JUL-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-JUL-2013 directing that There will be a case management conference, by teleconference on August 6, 2013, commencing at 11:00 placed on file on 29-JUL-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 29-JUL-2013 re: by email informaing the Court of the dates of availability for a CMC of the parties.

Memorandum to file from Annette Houle, Ottawa dated 29-JUL-2013 parties provided their availability for a CMC. The parties are available after 2:00 on July 30, 2013 and all day on August 6, 2013 placed on file.

Acknowledgment of Receipt received from all parties with respect to Oral Direction (Aronovitch, P.) dated July 22, 2013 placed on file on 23-JUL-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 22-JUL-2013 directing that "By July 26, 2013, parties are to provide their availability to attend a 30 minute case conference in the two weeks following, to discuss the necessity and possible timing of a joint pre-trial conference." placed on file on 22-JUL-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 12-JUL-2013 re: the requisition for PTC and Apotex's letter dated 28-Jun-2013 providing a status report re: mediation

Letter from Plaintiff dated 02-JUL-2013 Providing further dates of availability to those listed in the Request for a Pre-Trial Conferenece received on 02-JUL-2013

Affidavit of service of Mirella Ricci sworn on 28-JUN-2013 on behalf of Plaintiff confirming service of doc 83 upon all parties by telecopier on 28-JUN-2013 filed on 28-JUN-2013

Requisition for pre-trial conference from Plaintiff filed on 28-JUN-2013 Tariff Any other action - $300.00

Letter from Plaintiff dated 28-JUN-2013 updating the Court (Aronovitch, P.) pursuant to the Direction dated June 3, 2013 of the dates fixed for further settlement conferences. received on 28-JUN-2013

Toronto 27-JUN-2013 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Continuation of the Case Management Conference Result of Hearing: The Mediation scheduled for 5-8-Nov, 2013,is re-scheduled to Nov 18-21 at 10:00am. A case management conference will be held Nov. 4 at 10:00 for 2 hours. Parties are to send mediation material(minus exhibits) to Court. held in chambers Duration per day: 27-JUN-2013 from 10:00 to 10:35 Courtroom : Judge's Chambers - Toronto Court Registrar: Jacqueline Smith Total Duration: 35min Appearances: Mr. Jerry topolski 416-597-6262 representing Plaintiff Mr Ken Crofoot 416-597-6262 representing Plaintiff Mr David Scrimger 416-597-6262 representing Plaintiff Ms. Jane Caskey 416-216-4000 representing Defendant Ms Jordana Sanft 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 883 page(s) 195 - 196 Abstract of Hearing placed on file

Status report on behalf Apotex (sent to CMJ on 10-Jun-2013) received on 07-JUN-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 3-Jun-2013 placed on file on 05-JUN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-JUN-2013 directing that parties are to advise the case management judge of the dates fixed for further settlement conferences within a week of the dates having been fixed placed on file on 03-JUN-2013

Copy of Letter from Norton Rose Fulbright Canada LLP / s.e.n.c.r.l., s.r.l. dated 13-MAY-2013. re: Change of company name. Copy placed on 62 files. placed on file on 29-MAY-2013 Original placed on Court File No. T-2022-89

****** CANCELLED ****** Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-JUN-2013 directing that Parties are to sdvise the case management judge of the dates fixed for further settlement conferences within a week of the dates having been fixed placed on file on 03-JUN-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 30-MAY-2013 pursuant to paragraph 2 of the Order dated 24-Apr-2013 (sent to CMJ on 31- May 2013) received on 31-MAY-2013

Copy of Order dated 13-MAY-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-2101-09

Toronto 13-MAY-2013 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Mediation scheduled for 28-31- May, has been adjourned. A Case Management Conference will be held 27-Jun-2013 @ 10am, Mediation scheduled 5-8 Nov,2013 Expert reports(text only) to be submitted for the mediation process. held in chambers Duration per day: 13-MAY-2013 from 10:30 to 11:20 Courtroom : Judge's Chambers - Toronto Court Registrar: Jacqueline Smith Total Duration: 50min Appearances: Mr Ken Crofoot 416-597-6262 representing Plaintiff Ms Jane Caskey 416-216-4000 representing Defendant Ms Jordana Sanft 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 880 page(s) 365 - 366 Abstract of Hearing placed on file

Draft Order concerning the Trial Management Conference held on May 9, 2013. received on 10-MAY-2013

Ottawa 09-MAY-2013 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: Extension of 1 week granted. Mr. Topolski to send a draft order to the Court held by way of Conference Call Duration per day: 09-MAY-2013 from 01:30 to 01:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Benoit Labelle Total Duration: 15min Appearances: Mr. Jerry Topolski (416) 597-5907 representing Plaintiff Ms. Jordana Sanft, Ms. Jane Caskey, Mr. Patrick Kierans (416) 216-4798 representing GlaxosmithKline Mr. Christopher Tan and Mr. Warren Sprigings (416)777-0888 representing Pharmascience in T-643-10 Ms. Alisse Houwelling (416) 865-6600 representing Pharmascience in T-2101-09 Comments: Matter heard with T-643-10 and T-2101-09. Minutes of Hearing entered in Vol. 880 page(s) 249 - 251 Abstract of Hearing placed on file

Letter from Apotex dated 08-MAY-2013 requesting an urgent trial management conference with Justice Snider to request an extension of time for the delivery of expert reports due May 15, 2013 received on 08-MAY-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-May-2013 placed on file on 07-MAY-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-MAY-2013 directing that in light of correspondence from GSK and Apotex dated May 6, 2013, respectively, parties are advised to request a teleconference with Snider J. to deal with the request for an extension. The case management conference fixed for 3:00 p.m. today is accordingly adjourned sine die. placed on file on 07-MAY-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 06-MAY-2013 in reply to GSK's letter dated 6-May-2013 (given to the CMJ on 7-May-2013 at 9:30 a.m.) received on 07-MAY-2013

Letter from GSK dated 06-MAY-2013 in response to Apotex's correspondence dated 2-May-2013 (given to the CMJ on May 7, 2013 at 9:30 a.m.) received on 06-MAY-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-MAY-2013 directing that a case management teleconference is scheduled on May 7, 2013 at 3:00 p.m. GSK shall serve and file a response to Apotex's correspondence dated May 2, 2013, if any, by May 6, 2013 placed on file on 03-MAY-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 02-MAY-2013 requesting a CMC to discuss issues that arose that are making it difficult for Apotex to complete their expert report which are currently due May 15, 2013 (communicated to the CMJ on 3-May-2013) received on 02-MAY-2013

Copy of Order dated 24-APR-2013 rendered by Roza Aronovitch, Prothonotary concerning timetable placed on file. Original filed on Court File No. T-2101-09

Draft Order concerning direction dated 4-Mar-2013 and letter of 17-Apr-2013 received on 19-APR-2013

Communication to the Court from the Registry dated 18-APR-2013 re: ID 418

Letter from defendants in T-2101-09 dated 17-APR-2013 further to the direction of March 4, 2013 enclosing a consolidated timetable received on 17-APR-2013

Acknowledgment of Receipt received from all parties with respect to ID #416 (Copy of Order placed on T-2101-09) placed on file on 21-MAR-2013

Copy of Order dated 21-MAR-2013 rendered by Roza Aronovitch, Prothonotary concerning Motion Doc. #71 placed on file. Original filed on Court File No. T-2101-09

Acknowledgment of Receipt received from all parties by email with respect to the Direction of the Court (Snider J.) dated March 21, 2013. placed on file on 21-MAR-2013

Oral directions received from the Court: The Honourable Madam Justice Snider dated 21-MAR-2013 directing that "The Court is amenable to receiving the Trial Record on November 22, 2013." placed on file on 21-MAR-2013

Draft Order relating to Motion Doc. No. 71 approved as to form and content by all parties (sent to CMJ on 20-Mar-2013) received on 19-MAR-2013

Letter from Defendants in Court File T-2101-09 dated 14-MAR-2013 Advising that parties consent to the submission of trial records on November 22, 2013, and asking whether this is acceptable to the Court. received on 14-MAR-2013

Toronto 04-MAR-2013 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: The trial of files T-643-10 & T-2109-09 will take place Jan 7/14 in Toronto. The Pharmascience tials shall be consolodated with T-14-09. The consolodated trial will continue for a duration of 40 days. held in Court Duration per day: 04-MAR-2013 from 03:30 to 04:35 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Michael Pace Total Duration: 1h 5min Appearances: Patrick Kierans 416-216-3904 representing GSK Jane Caskie 416-216-1925 representing GSK Jordana Sanft 416-216-1925 representing GSK Daniel Daniele 416-216-1925 representing GSK Carole Hitchman 416-865-8259 representing Pharmascience Alissa Houweling 416-865-8259 representing Pharmascience Warren Sprigings 416-777-0888 representing Pharmascience Christopher Tan 416-777-0888 representing Pharmascience David Scrimger 416-597-6262 representing Apotex Ken Crowfoot 416-979-2211 representing Apotex Comments: Mr. Daniele took minutes for counsel. Minutes for the Court on files T-2101-09, T-643-10 & T-14-09 can be found with T-2101-09. Mr. Charles Kinzig(VP for GSK) sat in this conference. Minutes of Hearing entered in Vol. 876 page(s) 376 - 377 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Written Directions of the Court dated 4-MAR-2013 placed on file on 04-MAR-2013

Copy of Order dated 05-MAR-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-2101-09

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 04-MAR-2013 directing that "The parties are to resubmit a consolidated timetable after March 4, 2013 including: 1. The fixing of trial date for the three actions and the number of days for trial 2. A timetable for status reports 3. Dates for the filing of trial records after confirmation by Justice Snider 4. A fixed date by which parties will request a trial management conference 5. A mechanism for reporting on the date of any further settlement conferences and reporting to the Court thereafter." placed on file on 04-MAR-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 20-FEB-2013 re: consolidated timetable of steps further to the Direction of the Court 4-FEB- 2013

Oral directions received from the Court: The Honourable Madam Justice Snider dated 28-FEB-2013 directing that the TMC originally scheduled for March 4 /13 @ 3:00 is now scheduled for 3:30 March 4/13. placed on file on 28-FEB-2013

Draft Order concerning letter of 15-Feb-2013 (sent up to CMJ on 20-Feb-2013) received on 19-FEB-2013

Letter from counsel for PMS in T-2101-09 dated 15-FEB-2013 providing a consolidated timetable as required by the direction dated 4-Feb-2013 received on 15-FEB-2013

Oral directions received from the Court: The Honourable Madam Justice Snider dated 13-FEB-2013 directing that "A Trail Management conference will take place March 4, 2013 in Toronto in person at 3 pm, for a duration of no longer that 2 hours." placed on file on 13-FEB-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 11-FEB-2013 requesting a trial management conference with Justice Snider as directed by Madam Aronovitch's direction dated 4-Feb-2013 Letter scanned to Trial Judge's attention. received on 11-FEB-2013

Letter from GSK dated 08-FEB-2013 providing a status report as required by par. 8(a) of the Order of May 25, 2012(sent to the CMJ on 11-Feb-2013) received on 08-FEB-2013

Acknowledgment of Receipt received from All parties with respect to the Oral Directions (2) from Aronovitch, P. dated February 4, 2013. placed on file on 04-FEB-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 04-FEB-2013 directing that "Re: Correspondence on behalf of GSK dated January 30, 2013, requesting and extension of time until June 28, 2013 to serve and file its request for PTC Granted. In light of the trial of the three actions in January 2014, by February 15, 2013, parties are to file one consolidated revised timetable of further steps in the three actions." placed on file on 04-FEB-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 04-FEB-2013 directing that "Re: Correspondence on behalf of GSK dated January 28, 2013 and on behalf of Apotex and Pharmascience dated February 1, 2013. By February 11, 2013, parties are to jointly request a trial management conference with Justice Snider to fix the length of the trial of the three actions starting on January 13, 2014." placed on file on 04-FEB-2013 Confirmed in writing to the party(ies)

****** CANCELLED ****** Responding Chart on behalf of Apotex in response to Lilly's refusals motion doc. 862 revised further to the direction of the Court dated 4-Feb-2013 (submitted electronically through the CMT e-mail and only two copies made) (sealed pursuant to the Confidentiality Order dated 8-Nov-2007) filed on 04-FEB-2013

Memorandum to file from Julie Dulac dated 04-FEB-2013 the parties' correspondence dated 28-Jan-2013 and 1-Feb-2013 submitted further to the Court's direction of 25-Jan-2013 was placed before the CMJ today placed on file.

Letter from PMS in T-643-10 on their's and PMS in T-2101-09 and Apotex's behalf dated 01-FEB-2013 providing submissions as required by the Court's direction dated 25-Jan-2013 received on 01-FEB-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 30-Jan-2013 placed on file on 31-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-JAN-2013 directing that further to Mr. Tan's letter dated 28-Jan-2013 requesting an extension of time until 1-Feb-2013 to comply with the Court's direction of 25-Jan-2013 the request is granted placed on file on 30-JAN-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 29-JAN-2013 re: the parties' correspondence dated 28-Jan-2013

Letter from counsel for PMS in T-643-10 dated 28-JAN-2013 writing on their behalf and on behalf of counsel for PMS in T-2101-09 and counsel for Apotex in T-14-09, requesting an extension of time to comply with the Court's direction dated 25-Jan-2013 received on 28-JAN-2013

Letter from GSK dated 28-JAN-2013 in response to the Court's direction of 25-Jan-2013 received on 28-JAN-2013

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated January 24, 2013. placed on file on 25-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 24-JAN-2013 directing that Re: Trial dates: T-2101-09, T-643-10 and T-14-09. It is my understanding that in the course of a mediation of the issues in the above-noted actions, held in December 2012, the parties reached an agreement to vacate the dates for the trial of the actions in T-2101-09 and T-643-10, set down for hearing for 40 days commencing on September 9, 2013, before Justice Snider, and instead, have agreed to have the trial of the three actions proceed together on the basis of consolidated expert evidence, before Justice Snider, on January 13, 2014, for 25 days, being the dates fixed for the trial of T-14-09 alone. Before the September dates can be vacated, the parties will have to confirm the above-noted agreement, and that the 25 days set aside in January will suffice for the trial of the three actions. Parties are reminded that the 40 days in September had included consideration of the time needed for simultaneous translation. Parties are to confirm, or comment, including as to the sufficiency of the 25 days, by no later than January 28, 2013 placed on file on 24-JAN-2013 Confirmed in writing to the party(ies)

Copy of Written Direction dated 23-JAN-2013 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

Letter from PMS in T-2101-09 dated 16-JAN-2013 attaching a draft direction re: the CMC which took place on 11-Jan-2013 sent the the CMJ on 17-Jan-2013 received on 16-JAN-2013

Ottawa 11-JAN-2013 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to reschedule the refusals motions in T-2101-09 and T-643-10 Result of Hearing: See abstract in T-2101-09 held by way of Conference Call in chambers Duration per day: 11-JAN-2013 from 10:25 to 10:55 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jenene Roberts 416-849-6913 representing Plaintiff Jordana Sanft and Keith Aguilera 416-216-1925 representing Defendant Minutes of Hearing entered in Vol. 873 page(s) 454 - 455 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 8-Jan-2013 placed on file on 08-JAN-2013

Letter from GSK dated 09-JAN-2013 requesting that the refusals motions which were to take place on January 9, 10 and 11 and adjourned, be rescheduled the week of January 14th, 2012 received on 09-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 08-JAN-2013 directing that a case management teleconference will take place on Friday January 11, 2013 at 10:00 a.m. to discuss rescheduling of the refusals motions originally scheduled to take place on Janaury 9, 10 and 11, 2013 and now adjourned placed on file on 08-JAN-2013 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 20-Dec-2012 placed on file on 21-DEC-2012

Copy of Order dated 21-DEC-2012 rendered by Roza Aronovitch, Prothonotary concerning motion doc. 74 placed on file. Original filed on Court File No. T-2101-09

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-DEC-2012 directing that the motion set down for hearing in Ottawa on December 21, 2012 is hereby adjourned to be heard in Ottawa on January 9, 2013 commencing at 9:30 a.m. for 4 hours. PMS and Apotex's motion to compel GSK (Dr. Krenitsky) is scheduled to be heard in Ottawa for 1.5 days commencing on January 10, 2013 at 9:30 a.m. placed on file on 20-DEC-2012 Confirmed in writing to the party(ies)

Draft Order concerning Motion Doc. No. 74 consented to by all parties received on 20-DEC-2012

Communication to the Court from the Registry dated 17-DEC-2012 re: PMS's status report dated 7-Dec-2012

Toronto 10-DEC-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Mediation Result of Hearing: Matter adjourned sine die held in Court Senior Usher: Anne Street 10-DEC-2012 Anne street 11-DEC-2012 Anne Street 12-DEC-2012 Duration per day: 10-DEC-2012 from 10:00 to 04:30 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith 11-DEC-2012 from 09:30 to 04:50 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith 12-DEC-2012 from 10:00 to 12:50 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith Total Duration: 2.5d Appearances: Mr. jerry Topolski 416-979-2211 representing Plaintiff Mr. Ken Crofoot 416-979-2211 representing Plaintiff Ms. Jane Caskey 416-216-3930 representing Defendant Ms. Jordana Sanft 416-216-3930 representing Defendant Minutes of Hearing entered in Vol. 872 page(s) 313 - 314 Abstract of Hearing placed on file

Letter from Defendant dated 07-DEC-2012 in response to Plaintiff's letter of the same date received on 07-DEC-2012

Letter from Plaintiff dated 07-DEC-2012 in regards to the mediation received on 07-DEC-2012

Letter from Plaintiff dated 07-DEC-2012 Update report on proceedings as provided in paragraph 8(d) Order dated May 25,2012, for the attention Prothonotary Aronovitch. received on 07-DEC-2012

****** CANCELLED ****** Covering letter from GSK dated 19-NOV-2012 concerning Doc. Nos. 71 74 placed on file on 19-NOV-2012

Ottawa 28-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 71 on behalf of Apotex Inc. Result of Hearing: Matter partially granted held in Court Senior Usher: S. Young 03-DEC-2012 Duration per day: 28-NOV-2012 from 10:00 to 11:45 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 29-NOV-2012 from 09:30 to 05:05 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 30-NOV-2012 from 09:30 to 03:20 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 2d Appearances: Christopher Tan and Patrick Hui(on behalf of Goodmans just for this hearing) 416-777-2647 representing Apotex Keith Aguilera and William Pellerin 416-216-1925 representing GSK Draft Decision to be submitted by PMS by 07-Dec-2012 Minutes of Hearing entered in Vol. 872 page(s) 3 - 25 Abstract of Hearing placed on file

Sealed envelope pursuant to protective order dated 7-Dec-2009 on behalf of GSK purporting to contain information sought by the Court in the direction dated 27-Nov-2012 Received on 28-NOV-2012

Acknowledgment of Receipt received from all parties with respect to the Oral Direction of Aronovitch P., dated November 27, 2012 placed on file on 27-NOV-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-NOV-2012 directing that "Plaintiffs are to make preliminary submissions in writing, in point form by way of an overview, regarding the identity and relationship of the corporate plaintiffs, their respective roles in the manufacture, promotion and sale of valacyclovir, in Canada. Any agreements of the parties that relate to the above are to be noted by reference to the production found in the joint book of documents, which is to include a brief description of the nature of the document." placed on file on 27-NOV-2012 Confirmed in writing to the party(ies)

Ottawa 22-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the Court decided on the order in which the motions will be dealt with on 28-Nov-2012 held in chambers by way of Conference Call Duration per day: 22-NOV-2012 from 10:00 to 10:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Janine Roberts 416-597-6262 representing Apotex Inc. Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Minutes of Hearing entered in Vol. 871 page(s) 275 - 277 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Rosamaria Longo confirming service of doc. no. 71 upon GSK by e-mail on 06-NOV-2012 filed on 19-NOV-2012

Letter from Defendants in T-2101-09 dated 22-NOV-2012 advising that 65 questions need adjudication in motion to compel GSK re: Dr. Krenitsky received on 22-NOV-2012

Book of authorities of PMS re: motion doc 74 in T-14-09 received on 19-NOV-2012

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of doc. nos. 73, 76, 77 and authorities upon all parties by personal service on 19-NOV-2012 filed on 19-NOV-2012

Covering letter from GSK dated 19-NOV-2012 concerning doc nos. 76, 77, 73 placed on file on 19-NOV-2012

Covering letter from PMS dated 19-NOV-2012 concerning doc. no. 78 and authorities placed on file on 19-NOV-2012

Solicitor's certificate of service on behalf of Rosamaria Longo confirming service of docs. 78 and Book of authorities upon GSK by personal service on 19-NOV-2012 filed on 19-NOV-2012

Joint book of authorities of Apotex and PMS re: motion to compel GSK re: Dr. Krenitsky (motion doc. 71) received on 19-NOV-2012

GSK's book of authorities re: motion 71 and 74 in this file and motion doc. 74 in T-643-10 and motion docs. 110, 114, 118 and 122 in T-2101-09 (only entered in this file) received on 19-NOV-2012

Joint book of relevant documents re: motion to compel GSK (Dr. Krenitsky) (motion record doc. 73)(only filed in T-14-09)(sealed) filed on 19-NOV-2012

Joint brief of relevant documents re: PMS' and Apotex's motion to compel GSK (Roll and Vojir)(re: motion record doc. 76 only filed in T-14-09) (sealed) filed on 19-NOV-2012

Motion Record containing the following original document(s): 74 75 Number of copies received: 3 on behalf of PMS and Apotex (sealed)(motion record only filed in T-14-09) filed on 19-NOV-2012

Chart re: motion doc. 74 filed on 19-NOV-2012

Notice of Motion on behalf of PMS and Apotex returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling GSK (re: Cindy Roll and Norman Vojir) filed on 19-NOV-2012

Motion Record containing the following original document(s): 71 72 Number of copies received: 3 on behalf of GSK (complete motion record only filed in T-14-09) filed on 19-NOV-2012

Responding chart re: motion doc. 71 filed on 19-NOV-2012

Notice of Motion on behalf of Plaintiff returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling GSK (Dr. Krenitsky) filed on 19-NOV-2012

Ottawa 08-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss issues raised in correspondence dated November 1, 2, and 6, 2012 Result of Hearing: The Court gave the parties instructions on how to handle the issues held in chambers by way of Conference Call Duration per day: 08-NOV-2012 from 03:00 to 03:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: Dave Scrimger 416-597-6262 representing Apotex Inc. Jordana Sanft 416-216-4798 representing GSK Minutes of Hearing entered in Vol. 870 page(s) 373 - 375 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-Nov-2012 placed on file on 07-NOV-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-NOV-2012 directing that a CMC by TC will take place on 8-Nov-2012 at 3:00 p.m. placed on file on 07-NOV-2012 Confirmed in writing to the party(ies)

Letter from GSK dated 06-NOV-2012 in response to Apotex's letter dated 2-Nov-2012 (given to the CMJ on 7-Nov- 2012) received on 06-NOV-2012

Communication to the Court from the Registry dated 02-NOV-2012 re: (verbal communicattion) GSK's letter dated 1-Nov-2012 and Apotex's response dated 2-Nov-2012. The Court asked me to advise GSK that before calling a CMC she would await a response from GSK to Apotex's letter dated 2-Nov-2012

Letter from Apotex dated 02-NOV-2012 in response to GSK's letter dated 1-Nov-2012 received on 02-NOV-2012

Letter from GSK dated 01-NOV-2012 re: the fact that they were served with a Notice of Inter Partes Testing and requesting a CMC so that the issues can be resolved received on 01-NOV-2012

MEMORANDUM to CMJ- Aronovitch, P., from S.Mbuyi, Actions Section enslocing certified copy of Reasons for Order ad Order doc.70 of O'Keefe, J. placed on file on 30-OCT-2012

Acknowledgment of Receipt received from parties with respect to doc.70 placed on file on 29-OCT-2012

Reasons for Order and Order dated 29-OCT-2012 rendered by The Honourable Mr. Justice O'Keefe Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 51 Result: "THIS COURT ORDERS that: 1.The Prothonotary's order is set aside with respect to the following questions in Schedule "C" to the order: Category 1: Items 2, 11, 29 Category 4: Items 68-69, 73, 80-82, 87, 98-99 Category 8: Items 162, 163, 165 2. Pharmascience Inc., Laboratoire Riva Inc., Pro Doc Limitée, Dominion Pharmacal, Zymca Pharmaceuticals Inc., Pharmel Inc. and Apotex Inc. shall have their costs of the motion." Filed on 29-OCT-2012 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1172 page(s) 317 - 319

Acknowledgment of Receipt received from all parties with respect to the written direction of Aronovitch, P. dated October 19, 2012 placed on file on 19-OCT-2012

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 19-OCT-2012 directing that 1. Second-round motions to compel a) The second-round motions to compel, previously ordered to take place for five days in Toronto commencing on November 26, 2012, are hereby adjourned to commence on November 28, 2012, at 10:00 a.m. in Ottawa. b) The parties' motions in respect of financial issues shall be heard on November 28 and 29, 2012, in Ottawa. c) Apotex and PMS et al.'s motion in respect of scientific issues shall be heard on November 30, 2012, (and if necessary, December 21, 2012) in Ottawa. Motion records for second-round motions to compel The dates for the parties to exchange their moving and responding motion records, previously ordered to occur on October 26 and November 16, 2012, respectively, are hereby amended as follows: a) Moving parties¿ motion records shall be served by November 2, 2012. b) Responding parties¿ motion records shall be served and filed, in Ottawa, to the attention of Julie Dulac, by November 19, 2012. placed on file on 19-OCT-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 16-OCT-2012 re: the parties' draft direction re: CMC held 9-Oct-2012

Draft direction concerning CMC held on 9-Oct-2012 consented to by all parties received on 12-OCT-2012

Ottawa 09-OCT-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss changes to the November hearing dates Result of Hearing: Ms. Sanft will prepare a draft order and submit it by Friday October 12, 2012 held in chambers by way of Conference Call Duration per day: 09-OCT-2012 from 03:00 to 03:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 25min Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Apotex Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Comments: The hearing will begin at 10:00 am on November 28, 2012 and continue on November 29 and 30th and further on December 21, 2012 and moving parties records are now due November 2 and responding November 19, 2012 Minutes of Hearing entered in Vol. 868 page(s) 453 - 457 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of 2-Oct-2012 placed on file on 02-OCT-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 02-OCT-2012 directing that a case management teleconference will take place on 9-Oct-2012 at 3:00 pm placed on file on 02-OCT-2012 Confirmed in writing to the party(ies)

Copy of Notice of Discontinuance on behalf of Appellant placed on file on 20-SEP-2012 Original filed on Court File No. A-292-12

Toronto 12-SEP-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the mediation has been scheduled for 10-DEC-2012 and is scheduled to run for 3 days starting at 10:00 each day. The first round of brief exchange is due 12-NOV-2012, the second round is due 5-DEC-2012 held in ADR room Senior Usher: Ken Massey Duration per day: 12-SEP-2012 from 01:00 to 02:00 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 1h Appearances: Mr. Crofoot 416-597-4110 representing Plaintiff Ms. Caskey, Ms. Sanft 416-216-1899 representing Defendant Minutes of Hearing entered in Vol. 867 page(s) 424 - 425 Abstract of Hearing placed on file

Letter from GlaxoSmithKline Inc. dated 11-SEP-2012 providing the court with an agenda for the CMC scheduled for 12-SEP-2012 received on 11-SEP-2012

Letter from Counsel from Pharmascience Inc. dated 11-SEP-2012 providing the court with an agenda for the in person CMC scheduled for 12-SEP-2012 received on 11-SEP-2012

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 23-AUG-2012 directing that the CMC shall reconvene on 12-SEP-2012 at 1:00 and will be in person placed on file on 23-AUG-2012

Communication to the Court from the Registry dated 15-AUG-2012 re: Apotex's status report dated 13-Aug-2012

Toronto 23-AUG-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the matter will reconvene 12-SEP-2012 starting at 1:00 pm and will be held in person. The purpose of the in person CMC will be to discuss the up coming motion. Ms. Hitchman will provide the court with a Brief of Documents. held by way of Conference Call in chambers Duration per day: 23-AUG-2012 from 01:10 to 01:40 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 30min Appearances: Mr. Crofoot 416-597-4110 representing Plaintiff Ms. Sanft, Ms. Casky, and Mr. Aguilera 416-216-4798 representing Defendant Minutes of Hearing entered in Vol. 866 page(s) 493 - 494 Abstract of Hearing placed on file

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 15-AUG-2012 directing that a CMC has been scheduled for 23-AUG-2012 starting at 1:00PM placed on file on 15-AUG-2012

Letter from Defendant dated 10-AUG-2012 requesting a CMC with Prothonotary Aalto to discuss dates for a DRC received on 10-AUG-2012

Letter from Apotex Inc. dated 13-AUG-2012 providing update on scheduling orders of the court. received on 13-AUG-2012

Letter from GSK dated 01-AUG-2012 per par. 4 of the Order dated 25-May-2012 advising of dates of meeting to discuss unanswered questions received on 01-AUG-2012

Memorandum to file from C. Doré, Ottawa dated 09-JUL-2012 A copy of the Notice of Appeal was sent to the Case Management Judge. (Aronovitch, P.) placed on file.

Copy of Notice of Appeal (Appeal Court File No. A-292-12 ) appealing the Order of The Honourable Mr. Justice O'Keefe dated June 11, 2012. filed in the Court of Appeal on 21-JUN-2012 on behalf of Appellant placed on file on 06-JUL-2012

Communication to the Court from the Registry dated 26-JUN-2012 re: Letters from parties dated June 21 and June 22, 2012.

Letter from Plaintiff dated 22-JUN-2012 in response to GSK's letter of June 21, 2012. received on 22-JUN-2012

Letter from Defendant GSK Inc. dated 21-JUN-2012 Pursuant to paragraph 31 of Mr. Justice O'Keefe's decision dated June 11, 2012, the parties were given 10 days to request deletion of any material from the decision that they believe is confidential. GSK submits that the questions excerpted at paragraph 15 of the decision contain information that is confidential to GSK. In particular. item X's 2, 11, and 29 contain references to GSK's confidential scientific work. Accordingly, GSK respectfully requests that the text of Item #'s 2, 11, and 29 be deleted or redacted in the public version of the reasons. received on 21-JUN-2012

Copy of Confidential Draft Reasons for Order and Order dated 11-JUN-2012 rendered by The Honourable Mr. Justice O'Keefe placed on file. Original filed on Court File No. T-2101-09

Communication to the Court from the Registry dated 13-JUN-2012 re: GSK's status report dated 8-Jun-2012

Letter from GSK dated 08-JUN-2012 providing a status report pursuant to the Order of May 25, 2012 received on 08-JUN-2012

Letter from Apotex dated 31-MAY-2012 in response to GSK's letter requesting a mediation before Aalto P. (sent to SROs in Toronto on 31-May-2012 with a request that it be placed before Aalto P.) received on 31-MAY-2012

Letter from Plaintiff dated 30-MAY-2012 requesting a case management conference with Prothonotary Aalto to discuss the conducting of a mediation in this matter. received on 30-MAY-2012

Acknowledgment of Receipt received from All parties with respect to Doc. #69 (Order from Aronovitch, P. dated May 25, 2012). placed on file on 25-MAY-2012

Order dated 25-MAY-2012 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. Second round examinations for discovery are to be completed by April 30, 2012. 2. Answers to undertakings or questions refused, if any, flowing from second round examinations for discovery are to be exchanged by June 29, 2012. 3. The parties shall exchange lists of questions flowing from second round examinations for discovery which have not been responded to by August 1, 2012. 4. The parties are to meet for one full day in person per motion to discuss the questions described in paragraph 3 above by October 5, 2012. The parties shall write to the Court by August 1, 2012, to advise of the date(s) for the meeting(s). 5. Motion records flowing from second round examinations for discovery are to be served by October 26, 2012. 6. Responding records flowing from second round examinations for discovery are to be served and filed by November 16, 2012. 7. The motions to adjudicate questions arising out of the second round examinations for discovery will be heard for five (5) days in Toronto commencing on November 26, 2012, commencing at 9:30 a.m. 8. The parties shall provide the Court with status reports to be filed as follows: (a) By GSK on June 8, 2012 and February 8, 2013; (b) By Apotex on August 12, 2012, and April 12, 2013; (c) By Pharmascience et al. in Court File No. T-2101-09 on October 12, 2012; and (d) By Pharmascience Inc. in Court File No. T-643-10 on December 7, 2012. Court File Nos. T-2101-09 and T-643-10: 9. The Plaintiffs in Court File Nos. T-2101-09 and T-643-10 shall serve and file requests for pre-trial conferences by December 14, 2012. The requirement under Rule 258(4) to submit expert reports with pre-trial conference memoranda is hereby waived. 10. Expert reports in chief shall be served by March 15, 2013. The expert reports in chief shall include the following: (a) GSK expert reports relating to infringement and infringement damages; and (b) Pharmascience et al. expert reports relating to validity; and (c) Pharmascience expert reports relating to section 8 damages. 11. Rebuttal expert reports shall be served by July 15, 2013. 12. Initial requests to admit facts and documents shall be served by July 15, 2013. 13. Service of proposed discovery read-ins shall be made by July 31, 2013. 14. GSK shall serve and file the trial record by July 31, 2013. 15. Responses to any requests to admit facts and documents shall be served by August 6, 2013. 16. Proposed reply expert reports, with notices of motion seeking leave to introduce such reports returnable at the hearing of the actions, shall be served by August 12, 2013. 17. Service of proposed related parts to discovery read-ins shall be made by August 23, 2013. 18. A requisition for a trial management conference shall be made by the plaintiffs in Court File Nos. T-2101-09 and T-643-10 by April 12, 2013, for a trial management conference to be held at least ninety (90) days before trial. Court File No. T-14-09: 19. Expert reports in chief shall be served by April 15, 2013. The expert reports in chief shall include the following: (a) GSK expert reports relating to infringement and infringement damages; and (b) Apotex expert reports relating to validity and section 8 damages. 20. Apotex shall serve and file a request for pre-trial conference by June 28, 2013. The requirement under Rule 258(4) to submit expert reports with pre-trial conference memoranda is hereby waived. 21. Initial requests to admit facts and documents shall be served by July 26, 2013. 22. Rebuttal expert reports shall be served by August 2, 2013. 23. Responses to any requests to admit facts and documents shall be served by August 16, 2013. 24. Proposed reply expert reports, with notices of motion seeking leave to introduce such reports returnable at the hearing of the action, shall be served by September 9, 2013. 25.

Affidavit of service of Gina Lucas sworn on 17-MAY-2012 on behalf of Plaintiff confirming service of doc 67 upon Defendant by telecopier on 13-APR-2012 filed on 18-MAY-2012

Second Amended Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 18-MAY-2012

Draft Order concerning CMC held May 15, 2012 (sent electronically to the CMj on 18-May-2012) consented to by all parties received on 18-MAY-2012

Ottawa 15-MAY-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the proposed amalgamated timetable submitted on 17-Apr-2012 Result of Hearing: the timetable was further amended and GSK will provide an amended version of the proposed timetable submitted 17-Apr-2012 by 18-May-2012 held in chambers by way of Conference Call Duration per day: 15-MAY-2012 from 03:00 to 03:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 25min Appearances: Jerry Topolski 416-597-5907 representing Apotex Jordana Sanft, Jane Casky and Keith Aguilera 416-216-4798 representing GSK Comments: The hearing of the refusals motions tentatively scheduled to begin October 29, 2012 is now scheduled to begin on November 26, 2012 for 5 days in Toronto. The dates to perfect the motions originally scheduled in the Order of 20-Dec-2011 are amended and will be reflected on the new proposed timetable due 18-May-2012 Minutes of Hearing entered in Vol. 862 page(s) 227 - 229 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 15-MAY-2012 re: in preparation for the CMC scheduled May 15, 2012

Acknowledgment of Receipt received from All parties with respect to Doc. #66 (Order from Aronovitch, P. dated April 24, 2012). placed on file on 24-APR-2012

Order dated 24-APR-2012 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The updated version of Apotex's Second Amended Reply and Defence to Counterclaim attached hereto is accepted for filing with the Court, and replaces the earlier version of the Second Amended Reply and Defence to Counterclaim currently on file. Filed on 24-APR-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1155 page(s) 152 - 153 Interlocutory Decision

Letter from GSK dated 19-APR-2012 advising that they take no position in respect of Apotex's proposed pleading amendments (provided to the CMJ on 19-Apr-2012) received on 19-APR-2012

Communication to the Court from the Registry dated 18-APR-2012 re: GSK's draft order rec'd 17-Apr-2012 re: CMC of 10-Apr-2012

Draft Order concerning CMC held on 10-Apr-2012 consented to by all parties received on 17-APR-2012

Communication to the Court from the Registry dated 16-APR-2012 re: the plaintiff's letter dated 13-Apr-2012

Letter from Plaintiff dated 13-APR-2012 attaching a copy of their proposed amended reply and defence to counterclaim and requesting an Order of the Court granting leave, to file the amended document received on 13-APR-2012

Ottawa 10-APR-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss mediation and timetables Result of Hearing: The CMJ will leave it up to the parties to communicate with Aalto P. and request a teleconference to discuss scheduling the mediation and the subject of the mediation. The CMJ asked GSK to prepare a consolidated timetable which includes all remaining timelines in all three files. held in chambers by way of Conference Call Duration per day: 10-APR-2012 from 10:00 to 11:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Jordana Sanft and Keith Aguilera 416-216-4000 representing GSK David Scrimger and Jerry Topolski 416-597-5907 representing Apotex Minutes of Hearing entered in Vol. 860 page(s) 239 - 243 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 05-APR-2012 re: in preparation for the CMC scheduled 10-Apr-2012

Letter from Counsel for PMS in T-2101-09 of behalf of all parties dated 05-APR-2012 in preparation for the CMC scheduled 10-Apr-2012 addressing the Court's concerns as stated in the direction of the Court dated 28-Mar-2012 received on 05-APR-2012

Acknowledgment of Receipt received from All parties with respect to Doc. #65 & Oral Direction of Aronovitch, P. dated March 28, 2012. placed on file on 28-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 28-MAR-2012 directing that "In preparation for the issuance of the timetable for the remaining steps in T-14-09, I have noted certain omissions or provisions requiring amendment in the operative timetable for T-643-10 and T- 2101-09 and T-14-09, dated February 2, 2012, amending the Order of January 31, 2012; in particular, paragraphs 2 and 5, 6 and 10. It appears that no date has been fixed for the delivery of expert reports-in-chief for T-643-10 and T-2101-09. The delivery date at paragraph 6 is too late for a trial beginning in September 2013. Leave is required for the delivery of reply evidence, yet paragraph 10 provides for the delivery of reply expert reports as of right. While the case conference of April 10 is called to discuss mediation; given that revised timelines for the delivery of expert reports will be required for the T-643-10 and T2101-09, parties are requested to file new timetables, on consent, by April 5 for discussion on April 10." placed on file on 28-MAR-2012 Confirmed in writing to the party(ies)

Order dated 28-MAR-2012 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. Expert reports in chief shall be served by April 15, 2013. The expert reports in chief shall include the following: (a) GSK expert reports relating to infringement and infringement damages; and (b) Apotex expert reports relating to validity and section 8 damages. 2. Initial requests to admit facts and documents shall be served by July 26, 2013. 3. Rebuttal expert reports shall be served by August 2, 2013. 4. Responses to any requests to admit facts and documents shall be served by August 16, 2013. 5. Any motions to adduce reply expert reports shall be served and filed by September 9, 2013, and made returnable before the trial judge at a date to be set by the trial judge. 6. Service of proposed discovery read-ins shall be made by November 29, 2013. 7. Apotex shall serve and file the trial record by December 11, 2013. 8. Service of proposed related parts to proposed discovery read-ins shall be made by December 20, 2013. 9. The plaintiff shall serve and file a request for pre-trial conference by June 30, 2013. The requirement under Rule 258(4) to submit expert reports with pre-trial conference memoranda is hereby waived. 10. A requisition for a trial management conference shall be made by the plaintiff at least ninety (90) days before trial. Filed on 28-MAR-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1152 page(s) 472 - 474 Interlocutory Decision

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Mar-2012 placed on file on 28-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-MAR-2012 directing that a case management teleconference will take place on April 10, 2012 at 10:00 placed on file on 27-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-MAR-2012 directing that the case management teleconference scheduled to take place today at 4:00 p.m. is adjourned to a date to be determined. The parties are to provide their availability by the end of the day tomorrow for a case management teleconference in the two weeks following placed on file on 19-MAR-2012 Confirmed in writing to the party(ies)

Letter from PMS in T-643-10 dated 16-MAR-2012 rquesting that the CMC scheduled on 19-Mar-2012 be adjourned as they are no longer available received on 19-MAR-2012

Letter from GSK dated 13-MAR-2012 attaching a draft proposed timetable on consent further to the CMC held on March 5, 2012 (forwarded to the CMJ on 13-Mar-2012) received on 13-MAR-2012

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated March 5, 2012. placed on file on 06-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 05-MAR-2012 directing that a case management teleconference is scheduled to take place on March 19, 2012 at 4:00 pm to discuss the mediation placed on file on 05-MAR-2012 Confirmed in writing to the party(ies)

Ottawa 05-MAR-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss timetable re: this file Result of Hearing: a revised timetable on consent is due in a week The Court scheduled a CMC by TC on March 19, 2012 in all three files to discuss mediation held in chambers by way of Conference Call Duration per day: 05-MAR-2012 from 03:15 to 03:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 25min Appearances: Dave Scrimger 416-979-2211 representing Apotex Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Minutes of Hearing entered in Vol. 858 page(s) 335 - 337 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 02-MAR-2012 re: the parties' proposed timetables in preparation for the CMC scheduled 5-Mar-2012

Letter from GSK dated 02-MAR-2012 providing it's proposed timetable in preparation for the CMC scheduled 5-Mar-2012 received on 02-MAR-2012

Letter from Apotex dated 02-MAR-2012 providing a proposed timetable in preparation for the CMC scheduled on 5-Mar-2012 received on 02-MAR-2012

Communication to the Court from the Registry dated 20-FEB-2012 re: the parties' letter re: status of discussions re: mediation

Letter from Apotex dated 17-FEB-2012 advising that the parties have not yet been able to come to an agreement with respect to the scope of the mediation and advising that they expect dicussions in this regard to continue but are not in a position to commit to a mediation until these issues are resolved received on 17-FEB-2012

Letter from GSK dated 17-FEB-2012 providing a report re: discussions among the parties re: mediation and advising that the parties where not able to come to an agreement as to the scope of the mediation received on 17-FEB-2012

Acknowledgment of Receipt received from all parties (Plaintiff ORALLY acknowledge; Defendant by EMAIL) with respect to the Oral Direction of the Court dated 13-FEB-2012 placed on file on 13-FEB-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 13-FEB-2012 directing that a case management conference is to be set down for March 5, 2012 at 3:00p.m. for a duration of one (1) hour. If the parties fail to reach consent in regards to a proposed timetable each party will file a seperate timetable for discussion at the case conference by March 2, 2012. placed on file on 13-FEB-2012 Confirmed in writing to the party(ies)

Letter from Defendant dated 08-FEB-2012 requesting a CMC to set the schedule for pre-trial steps. received on 08-FEB-2012

Copy of Amended Order dated 02-FEB-2012 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-643-10

Copy of Order dated 31-JAN-2012 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-14-09

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of Doc 63 upon Plaintiff by personal service on 27-JAN-2012 filed on 27-JAN-2012

Further Amended Statement of Defence and Counterclaim (GlaxoSmithKline Inc et al) filed on 27-JAN-2012

Affidavit of service of Inna Zahharova sworn on 27-JAN-2012 on behalf of Plaintiff confirming service of Doc. 61 upon Defendant and plaintiffs by counterclaim by email on 27-JAN-2012 filed on 27-JAN-2012

Amended (second) reply and defence to counterclaim filed on 27-JAN-2012

Letter from Defendant dated 27-JAN-2012 attaching a Draft Order with timelines established at the CMC 18-JAN-2012 received on 27-JAN-2012

Communication to the Court from the Registry dated 27-JAN-2012 re: Draft Order received on 27-JAN-2012 following CMC

Copy of a Letter from Plaintiff to Defendant dated 26-JAN-2012 attaching the proposed Second Amended Reply and Defense to Counterclaim received on 26-JAN-2012

Ottawa 18-JAN-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Counsel for PMS in T-2101-09 will provide a draft order by 27-Jan-2012 held in chambers Duration per day: 18-JAN-2012 from 03:05 to 04:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Plaintiff Jordana Sanft and Keith Aguilera 416-216-4798 representing Defendant Comments: See comments in T-2101-09 Minutes of Hearing entered in Vol. 855 page(s) 480 - 481 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 17-JAN-2012 re: in preparation for the CMC scheduled 18-Jan-2012

Letter from Glaxo dated 16-JAN-2012 providing a proposed timetable on consent in preparation for the CMC to be held on 18-Jan-2012 received on 16-JAN-2012

Communication to the Court from the Registry dated 28-DEC-2011 re: counsel for the plaintiff's in T-643-10 letter dated 23-Dec-2011

Letter from counsel for the plaintiff in T-643-10 dated 23-DEC-2011 providing status per Order of 2-May-2011 received at hearing on 28-DEC-2011

Letter from counsel for the defendants in T-2101-09 dated 21-DEC-2011 providing schedule for second round of discoveries received on 21-DEC-2011

Copy of Order dated 20-DEC-2011 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of 59 - Defendant's Responding Motion Record in sealed envelope upon Plaintiff by process server on 09-DEC-2011 filed on 09-DEC-2011

Communication to the Court from the Registry dated 19-DEC-2011 re: sending the draft proposed timetabled received 19-Dec-2011 to the CMJ by e-mail

E-mail from Apotex attaching a proposed timetable on consent further to the CMC held on 14-Dec-2011 received on 19-DEC-2011

Ottawa 14-DEC-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the timetable going forward Result of Hearing: A partial timetable was established. A draft order re: that timetable will be provided by end of day 19-Dec-2011. A further CMC by TC was scheduled on January 18th, 2011 to continue the discussion about timetable, discuss dates and venue for a judicially assisted mediation, scheduling of refusals motions arising out of the 2nd round of discoveries and discuss the issues raised in the confidential correspondence submitted December 13 and 14, 2011 held by way of video conference Senior Usher: R. Héroux Duration per day: 14-DEC-2011 from 02:10 to 03:30 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Plaintiff Keith Aguilera and Jordana Sanft 416-216-4000 representing Defendant Comments: The Court reminded the parties that the timetable should include a date by which they are to requisition a pre-trial conference and pay the fee even though the trial has already been scheduled and that a the PTC, the trial duration will be fine tuned. Minutes of Hearing entered in Vol. 854 page(s) 297 - 301 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 13-DEC-2011 re: in preparation for CMC of December 14th, 2011

Toronto 12-DEC-2011 BEFORE The Honourable Mr. Justice O'Keefe Language: E Before the Court: Motion Doc. No. 51 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Joe Mischuk Duration per day: 12-DEC-2011 from 09:38 to 11:33 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil Total Duration: 1h 55min Appearances: Carol Hitchman/Arif Mahmood 416-865-8259 representing Pharmascience(Plaintiffs in T-643-10/Defendants in T-2101-09) Lindsay Hill/David Scrimger 416-979-2211 representing Plaintiff Keith Aguilera/Jordana Sanft 416-216-3930 representing Defendant Court Reporter: Calypso Schincariol (ASAP Reporting Services Inc. 416-861-8720 12-DEC-2011 Transcript requested Minutes of Hearing entered in Vol. 854 page(s) 285 - 286 Abstract of Hearing placed on file

Letter from Defendant dated 13-DEC-2011 providing their proposed timetable received on 13-DEC-2011

Letter from Apotex dated 13-DEC-2011 re: proposed timetable received on 13-DEC-2011

Letter from Jean-Charles René (Norton Rose Canada LLP) dated 05-DEC-2011 re: name and address change. received on 05-DEC-2011

Sealed envelope pursuant to the Court Order dated Dec 7, 2009 on behalf of Defendant purporting to contain Responding Motion Record of GSK Filed on 09-DEC-2011

Joint Book of Authorities consisting of 4 volume(s) on behalf of all parties received on 09-DEC-2011 Sent directly to Presiding Judge

Sealed envelope pursuant to Protective Order dated 7-DEC-2009 on behalf of Plaintiff/Moving Party purporting to contain Joint Book of Relevant Documents (2 Volumes) Received on 07-DEC-2011

Sealed envelope pursuant to Protective Order dated 7-DEC-2009 on behalf of Plaintiff/Moving Party purporting to contain Motion Record containing the following original document (s): 57 Number of copies received: 3 Filed on 07-DEC-2011

Written Representations contained within a Motion Record on behalf of Plaintiff/Moving Party concerning Motion Doc. No. 51 filed on 07-DEC-2011

****** CANCELLED ****** Motion Record in response to Motion Doc. No. 51 containing the following original document(s): 55 Number of copies received: 3 on behalf of Defendant filed on 09-DEC-2011

****** CANCELLED ****** Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 51 filed on 09-DEC-2011

Letter from Defendant dated 09-DEC-2011 Enclose for filing following documents in respect of the motion hearing Dec 12, 2011; R's motion record GSK, Joint Authorities received on 09-DEC-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 01-DEC-2011 directing that The case management conference by teleconference scheduled for December 14, 2011 will now be heard by videoconference. If the parties indicate that the timetable will be on consent then the case management conference will be heard by teleconference. placed on file on 01-DEC-2011

Ottawa 01-DEC-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference To discuss extension of timelines for second round of discovery Result of Hearing: The timelines are to be fixed and placed in the new timetable which will be discussed at the case conference on December 14, 2011. held by way of Conference Call Duration per day: 01-DEC-2011 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 35min Appearances: Mr. Crofoot and Mr. Topolski 416-979-2211 representing Plaintiff Ms Sanft and Mr. Aigulera 416-216-4798 representing Defendant Comments: This matter was heard in conjunction with T-2101-09 and T-643-10 The Court Directed that the case management conference scheduled for December 14, 2011 would proceed at 2:00 by videoconference in lieu of a teleconference, but if the parties write to the Court that there is a timetable on consent the case management conference will then be heard by teleconference. Mr. Tan is to provide fixed dates for himself and his clients for discovery to Ms Sanft by December 6, 2011. These timelines are to be placed in the timetable submitted on December 13, 2011. The Court indicated that the timelines in the timetable will be fixed for the date that the Trial is presently scheduled for. Parties are also to have a provision in the timetable for samples motions. Minutes of Hearing entered in Vol. 853 page(s) 383 - 388 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 30-NOV-2011 re: Preparation of the file for the CMC on December 1, 2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-NOV-2011 directing that There will be a case management conference, by teleconference on December 1, 2011, commencing at 10:00 for thirty minutes. placed on file on 30-NOV-2011 Confirmed in writing to the party(ies)

Letter from Pharmascience Inc dated 25-NOV-2011 providing dates of availability for a case conference received on 25-NOV-2011

Letter from Pharmascience dated 25-NOV-2011 providing dates of availability for a case conference received on 25-NOV-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated November 22, 2011. placed on file on 23-NOV-2011

Letter from GSK dated 24-NOV-2011 providing its availability for a CMC the week of 28-Nov-2011 received on 24-NOV-2011

Communication to the Court from the Registry dated 24-NOV-2011 re: GSK's letter dated 23-Nov-2011 (sent electronically to the CMJ)

Letter from GSK dated 23-NOV-2011 advising of status of motions to amend pleadings received on 23-NOV-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 22-NOV-2011 directing that "By November 25, 2011 parties are to provide their availability to attend a case conference during the week of November 28, 2011 to discuss an extension of the timelines for the conclusion of the second round of discoveries. In the interim parties are to try to fix the dates for the completion of as much of the discoveries as possible by the end of February 2012." placed on file on 23-NOV-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 22-NOV-2011 re: sending the parties' correspondence re: moving up trial dates if dates become available to the Judicial Administrator and the CMJ as well as the correspondence re: issues with scheduling discoveries to the CMJ

Letter from Plaintiff dated 18-NOV-2011 re: GSK's letter re: issues with 2nd round of discoveries advising that it does not object to an extension to accomodate the availability of GSK in order that the discoveries can continue in the same format they have been held to date received on 18-NOV-2011

Letter from GSK dated 18-NOV-2011 further to the Order of March 2, 2011 providing dates for the 2nd round of discoveries and advising of difficulties with scheduling discoveries with Pharmascience and requesting direction from the Court received on 18-NOV-2011

Letter from Plaintiff dated 16-NOV-2011 in response to Ms. Hitchman's letter in T-2101-09 and T-643-10 dated 15-Nov-2011 advising that they agree that it would be preferable to have these matters tried just prior to the start of the Apotex hearing on January 13, 2014 received on 16-NOV-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 16-Nov-2011 placed on file on 16-NOV-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 16-NOV-2011 directing that "Glaxo is to advise as to the status of the motion to amend filed on July 15 2011 (doc 33 in T-14-09 and doc. 55 in T-2101-09) by no later than November 23, 2011." placed on file on 16-NOV-2011 Confirmed in writing to the party(ies)

Copy of Order dated 14-NOV-2011 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

Acknowledgment of Receipt received from All parties with respect to Doc. #54 (Order from Aronovitch, P. dated November 4, 2011). placed on file on 04-NOV-2011

Order (time and place) dated 04-NOV-2011 rendered by Roza Aronovitch, Prothonotary fixing Trial of the matter to be heard at Special Sitting in Toronto on 13-JAN-2014 to begin at 09:30 duration: 25d language: E Filed on 04-NOV-2011 cc's sent to parties entered in J. & O. Book, volume 1140 page(s) 103 - 104 Transmittal letters placed on file

Communication to the Court from the Registry dated 01-NOV-2011 re: the status report dated 28-Oct-2011

Letter from counsel for PMS in T-2101-09 dated 28-OCT-2011 providing status report per May 2, 2011 Order received at hearing on 28-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-OCT-2011 directing that granted the parties' request for an extension of the timeline set by paragraph 1k of the May 2, 2011 Order until November 30, 2011 placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from all parties with respect to the directions of the Court dated 21-Oct-2011 and 26-Oct-2011 placed on file on 26-OCT-2011

****** CANCELLED ****** Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-OCT-2011 directing that a case management teleconference is scheduled on October 27, 2011 at 10:00 a.m. to discuss a new date for the trial in 2013 placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 21-OCT-2011 directing that the parties' request for an extension of time to submit the draft orders pertaining to the motions to compel heard October 13 and 14, 2011 is granted until October 28, 2011 as requested placed on file on 21-OCT-2011 Confirmed in writing to the party(ies)

Letter from Defendant - GlaxoSmithKline Inc. dated 26-OCT-2011 Re: consent of all parties to additional time to 30-NOV-2011 to exchange answers to questions ordered to be answered from the refusals motion by 31-OCT-2011. cc to all parties received on 26-OCT-2011

Letter from counsel for PMS in T-643-10 on behalf of all counsel in these matters dated 21-OCT-2011 requesting an extension of time until 28-Oct-2011 to provide the draft orders re: motions to compel heard on October 13 and 14, 2011 (sent in pdf to the CMJ on 21-Oct-2011) received on 21-OCT-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direciton of Aronovitch, P. dated October 14, 2011. placed on file on 19-OCT-2011

Toronto 14-OCT-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: court will schedule a PTC:Dec. 14, 2011, parties are to submit a timetable Dec 13, 2011 to cmt-ott email. held in Court Senior Usher: Sybil Mirosolin Duration per day: 14-OCT-2011 from 10:00 to 11:50 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Jacqueline Smith Total Duration: 1h 50min Appearances: Ms. Jane Caskey 416-216-4000 representing Plaintiff Ms. Jordanna Sanft 416-216-4000 representing Plaintiff Mr. Christopher Tan 416-777-0888 representing Defendant Ms. Carol Hitchman 416-777-0888 representing Defendant Mr. Jerry Topolski 416-979-2211 representing Defendant Mr. David Scrimger 416-979-2211 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 227 - 228 Abstract of Hearing placed on file

Letter from Plaintiff dated 14-OCT-2011 advising that Apotex anticipates that it may require adducing some evidence in French but does not believe that the nature and extent of this evidence would jeopardise any current arrangement for the hearing of this matter and duration of trial received on 14-OCT-2011

Letter from GSK dated 13-OCT-2011 advising that the parties have agreed that mediation before trial is appropriate and that it may be incorporated into a scheduling order but that the parties have not agreed on the timing of the mediation ie before or after expert reports and asking that the timing, identity of the mediator and material for mediation be determined at the CMC in December received on 13-OCT-2011

Letter from GSK dated 12-OCT-2011 advising that they are in agreement with Apotex that 25 days are sufficient for the hearing of this action received on 13-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 14-OCT-2011 directing that a case management teleconference will take place on December 14, 2011 at 2:00 p.m. to discuss the timetable going forward. The parties are to file, jointly or separately, a proposed timetable, by noon on December 13th, 2011 at the cmt e-mail address placed on file on 14-OCT-2011 Confirmed in writing to the party(ies)

Toronto 21-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 50 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Sybil Mirosolin Duration per day: 21-SEP-2011 from 09:35 to 09:45 Courtroom : Courtroom No. 4-D - Toronto Court Registrar: Jacqueline Smith Total Duration: 10min Appearances: Mr. Ken Crofoot 416-979-2211 representing Plaintiff Ms. Jane Caskey 416-216-4000 representing Defendant Mr. Keith Aguilera 416-216-4000 representing Defendant Comments: The parties, will submit a draft order for issuing. Minutes of Hearing entered in Vol. 851 page(s) 43 - 44 Abstract of Hearing placed on file

Acknowledgment of Receipt received from All parties with respect to Doc. #53 (Order from Aronovitch, P. dated October 7, 2011). placed on file on 07-OCT-2011

Letter from Plaintiff dated 12-OCT-2011 advising that they maintain there position in previous correspondence dated March 22, 2011 re: trial length received on 12-OCT-2011

Order dated 07-OCT-2011 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 50 Result: granted in part (see order for details) Filed on 07-OCT-2011 certified copies sent to parties entered in J. & O. Book, volume 1136 page(s) 463 - 469 Interlocutory Decision

Copy of Order dated 07-OCT-2011 rendered by Roza Aronovitch, Prothonotary concerning motion doc 57 and 88 in T-2101-09 and motion doc 30 in T-14-09 placed on file. Original filed on Court File No. T-2101-09

Correction to General Sitting concerning Motion Doc. No. 51 Hearing added to General Sitting at Toronto on 12-DEC-2011 at 09:30 duration: 2h Language: E Reason for correction: parties agreed that matter could be heard at general sittings this day

Letter from Defendant dated 06-OCT-2011 confirming that motion doc. 51 is to be returnable for general sittings on 12-DEC-2011 at 9:30 in Toronto received on 06-OCT-2011

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of Doc. No. 51 upon Plaintiff by telecopier on 05-OCT-2011 filed on 05-OCT-2011

Notice of Motion on behalf of Defendant returnable (but no hearing date indicated at this time) for appealing order made by Prothonotary Aronovitch pronounced after motions were heard between 23-SEP-2011 and 26-SEP-2011 with respect to questions in Schedule "C" to be set aside. filed on 05-OCT-2011

SEALED NOTICE OF MOTION on behalf of Defendant returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel answers to undertakings filed on 15-JUL-2011

e-mail on behalf of counsel for GSK attaching a draft order on consent re: motion 32 (motion record doc 37. (sent electronically to the CMJ on 4-Oct- 2011) received on 04-OCT-2011

Copy of Order dated 28-SEP-2011 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

E-mail on behalf of GSK attaching an amended draft order pursuant to the request of the Court at the hearing of September 26, 2011 received on 27-SEP-2011

E-mail on behalf of GSK further to the Court's request at the hearing of September 23, 2011 attaching a draft direction to schedule a CMC on 14-Oct- 2011 following the continuation of the hearing of the motions to compel. Forwarded to the CMJ by e-mail placed on file on 26-SEP-2011

Letter from Defendants dated 19-SEP-2011 advising that its preference is that the trial in Court File No. T-643-10 be heard starting April 8, 2013 together with the trial in Court File No. T-2101-09. (Transmitted to the CMJ by e-mail) received on 19-SEP-2011

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of doc. 47 and 48 upon Plaintiff by process server on 13-SEP-2011 filed on 13-SEP-2011

Letter from Defendant dated 12-SEP-2011 describing in detail what documents they are filing with regards to the hearing of the motions to compel scheduled to be heard starting September 21 2011 received on 13-SEP-2011

Letter from Defendant dated 13-SEP-2011 suggesting the order in which the motions to compel should be heard received on 13-SEP-2011

Covering letter from Defendant dated 12-SEP-2011 concerning explaining the documents filed for the hearing of the motions to compel to be heard in Toronto on 21-Sep-2011 for 5 days placed on file on 13-SEP-2011

Transcript of the examination for discovery of John Hems, a representative of Apotex Inc. held on March 22 and 23, 2011 to accompany motion record doc 37 filed on 13-SEP-2011

Brief of relevant documents for motion to compel Apotex Inc. filed by the Defendant to accompany material filed re: motion filed as sealed envelope doc 32 and motion record doc. 37 filed on 13-SEP-2011

Solicitor's certificate of service on behalf of Jenene Roberts confirming service of doc 43 upon Defendant and the Plaintiffs by Counterclaim by courier on 12-SEP-2011 filed on 13-SEP-2011

Covering letter from Plaintiff dated 12-SEP-2011 concerning Doc. Nos. 43 44 45 placed on file on 13-SEP-2011

Brief of transcripts of the examination for discovery of Cyndy Roll and Norman Vojir to form part of the material filed in support motion doc 30 in T-14-09, doc 43 in T-643-10 and 50 in T-2101-09 filed on 13-SEP-2011

Pleadings Brief on behalf of Apotex to accompany their materials for their motion doc. 30 (motion record 64 in T-2101-09) and also PMS' material in their motions doc 50 and 57 in T-2101-09 (motion record 64 in T-2101-09) filed only in this file per instructions of the Court given at the CMC held on 8-Sep-2011 filed on 13-SEP-2011

Motion record on behalf of Apotex in response to GSK's motion to compel answers to questions arising out of the examination of John Hems (filed in sealed envelope as doc. 32)(sealed pursuant to Order of 7-Dec-2009) filed on 13-SEP-2011

Ottawa 13-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the scheduling of trial of these issues Result of Hearing: GSK is to provide a proposed schedule leading to mediation of certain aspects of these matters . GSK will advise if his client is agreable to proceeding with PMS's Section 8 in 2013 Apotex's in 2014. If not, both section 8s will be scheduled in 2014.GSK is to advise by 19-Sep-2011. Depending on what is decided, the duration of the trials will have to be adjusted and a further CMC will be scheduled to discuss the change to the durations held in chambers by way of Conference Call Duration per day: 13-SEP-2011 from 11:10 to 11:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: David Scrimger 514-397-4453(just for today) representing Plaintiff Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 849 page(s) 129 - 132 Abstract of Hearing placed on file

Ottawa 08-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the hearing of the motions to compel to be heard on 21-28 Sept and scheduling of motions to amend in this file and T-2101-09 Result of Hearing: The responding parties are to serve and file their responding record by noon on September 13, 2011 (which shall include an "aide-mémoire" containing pertinent documents and exhibits and a 5 column chart as described) accompanied by a covering letter explaining the content of the material. The Court consolidated the motion material and allowed the parties to file only one set of three copies of the responding material to be placed on one file. The parties are to advise as to the order in which the motions to compel will be heard by September 12, 2011. The motions to amend in this file and in T-2101-09 are to be made returnable on a general sitting on which Madam Prothonotary Aronovitch is sitting held in chambers by way of Conference Call Duration per day: 08-SEP-2011 from 01:05 to 02:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Ken Crofoot 416-597-4110 representing Plaintiff Jordana Sanft and Jane Caskey 416-216-4798 representing Defendant Comments: The responding motion records are to be filed in Ottawa by noon 13-Sep-2011 Minutes of Hearing entered in Vol. 848 page(s) 474 - 479 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 07-SEP-2011 re: Galxo's motion to amend to be scheduled

Covering letter from Defendants dated 02-SEP-2011 concerning doc. 42 placed on file on 02-SEP-2011

Written Submissions on behalf of Defendants concerning in preparation for the CMC on 13-Sep-2011 to discuss joint trial filed on 02-SEP-2011

****** CANCELLED ****** Solicitor's certificate of service on behalf of CHRISTOPHER TAN confirming service of DOC 40 upon Respondent by e-mail on 31-AUG-2011 filed on 01-SEP-2011

****** CANCELLED ****** Sealed envelope pursuant to Protective Order dated 12-jan-2011 on behalf of Pharmascience Inc. purporting to contain Moving Party Motion Record Filed on 01-SEP-2011

****** CANCELLED ****** Notice of Motion on behalf of Pharmascience Inc. returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel the representatives of the Responding Party to re-attend for examination for discovery filed on 01-SEP-2011

Solicitor's certificate of service on behalf of Jane E. Caskey confirming service of doc. 37 upon Plaintiff by process server on 31-AUG-2011 filed on 31-AUG-2011

Sealed envelope pursuant to order dated 7-dec-2009 on behalf of Defendant purporting to contain the Motion Record, - discovery of JH Filed on 31-AUG-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-AUG-2011 directing that the moving parties' motion records re: the motions to compel are to be served and filed by 31-Aug-2011 and the responding motion records are to be served and filed, in Ottawa, directly to the attention of Julie Dulac, by noon, on 9-Sep-2011 placed on file on 19-AUG-2011 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 18-AUG-2011 directing that the moving parties' motion record re: motions to compel shall be served and filed by August 31, 2011 and the moving parties' motion records by September 16, 2011 placed on file on 18-AUG-2011 Confirmed in writing to the party(ies)

Letter from counsel for the plaintiff in T-643-10 dated 17-AUG-2011 requesting an extension of time to file moving parties' motion records and responding motion records re: motions to compel received on 17-AUG-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 10-Aug-2011 placed on file on 10-AUG-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 10-AUG-2011 directing that the case management teleconference scheduled to take place on September 13 2011 at 2:00 p.m. will now take place at 11:00 a.m. placed on file on 10-AUG-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 10-AUG-2011 re: Apotex's status report dated 29-Jul-2011

Letter from Apotex dated 29-JUL-2011 providing a quartely status report and advising that they are meeting the timelines received on 29-JUL-2011

Affidavit of service of Darlene Power sworn on 22-JUL-2011 on behalf of Plaintiff confirming service of Written Submissions Doc. 35 upon all parties by telecopier on 22-JUL-2011 filed on 25-JUL-2011

Written Submissions of Apotex Inc. regarding the Request for a Joint Hearing filed on 25-JUL-2011

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of doc 32 33 upon Plaintiff by process server on 15-JUL-2011 filed on 15-JUL-2011

Notice of Motion on behalf of Defendant returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to amend the style of cause & to amend the Amended Statement of Defence filed on 15-JUL-2011

****** CANCELLED ****** Sealed envelope pursuant to Order of the Court on behalf of Defendant purporting to contain Notice of Motion (to compel answers) returnable Sept 21-23, 26, 27, 2011 Filed on 15-JUL-2011

Letter from Plaintiff dated 15-JUL-2011 advising that the Notice of Motion filed July 13, 2011 should in fact be treated as confidential. Envelopes are provided for all copies. received on 15-JUL-2011

Affidavit of service of Johanna Palacios sworn on 13-JUL-2011 on behalf of Plaintiff confirming service of doc. 30 upon Defendant by courier on 13-JUL-2011 filed on 13-JUL-2011

SEALED NOTICE OF MOTION on behalf of Plaintiff returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel answers to outstanding undertakings, under advisement and refusals (H.B. Radomski, 416-979-2211, P's Counsel) filed on 13-JUL-2011

Acknowledgment of Receipt received from all parties with respect to re: the direction of 23-Jun-2011 placed on file on 24-JUN-2011

Communication to the Court from the Registry dated 06-JUN-2011 re: Apotex's correspondence dated 3-Jun-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 24-JUN-2011 directing that The hearing of June 23, 2011 is adjourned to September 13, 2011 2:00 p.m. for 1.5 hours. Apotex's supplementary submissions are to be served and filed by July 22, 2011.Pharmascience's submissions are to be serve and filed by August 5, 2011 and GSK's submissions by September 2, 2011. placed on file on 23-JUN-2011 Confirmed in writing to the party(ies)

Ottawa 23-JUN-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss issues re: trial dates described in recent correspondence Result of Hearing: Direction to follow held in chambers by way of Conference Call Duration per day: 23-JUN-2011 from 03:05 to 04:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Jerry Topolski 416-597-5907 representing Plaintiff Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-3904 representing Defendant Minutes of Hearing entered in Vol. 846 page(s) 238 - 243 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 22-Jun-2011 placed on file on 23-JUN-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 22-JUN-2011 directing that a case management teleconference is scheduled on June 23, 2011 at 3:00 p.m. placed on file on 22-JUN-2011 Confirmed in writing to the party(ies)

Memorandum to file from Julie Dulac dated 21-JUN-2011 the Court asked that I contact the parties and attempt to schedule a CMC by TC to discuss the parties' latest correspondence placed on file.

Communication to the Court from the Registry dated 14-JUN-2011 re: verbal communication bringing Glaxo's letter dated 13-Jun-2011 to the attention of the case management prothonotary

Letter from GlaxoSmithKline Inc. dated 13-JUN-2011 "...We are in receipt of the letters from counsel...dated June 3, 2011. ...GSK should not be denied its right to have its patent adjudicated upon the earliest possible opportunity..." cc to Plaintiff received on 13-JUN-2011

Letter from Glaxo dated 08-JUN-2011 further to the instructions of the Court at the CMC on May 24, 2011 advising that all parties agree that the current schedule in respect of these actions (T-14-09, T-2101-09 and T-643-10) as set by the Order of May 2, 2011 does not need to be amended and will continue to govern the next steps of these actions (provided to the Court electronically on June 8, 2011) received on 08-JUN-2011

Letter from Apotex dated 03-JUN-2011 re: submissions re: the assignment of two separate trial dates in these three related files (T-14-09, T-2101-09 and T-643-10)(provided to the Court on June 6, 2011) received on 06-JUN-2011

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 26-May-2011 placed on file on 26-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-MAY-2011 directing that following the case conference of May 24, 2011, trial dates have been tentatively set aside as follows: T-2101-09 and T-643-10- 25-30 days, in English, starting April 8, 2013, at 9:30 a.m. in Toronto. T-14-09- 25-30 day in English, starting January 13, 2014 at 9:30 a.m. in Toronto. Same judge as above. placed on file on 26-MAY-2011 Confirmed in writing to the party(ies)

Ottawa 24-MAY-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held in chambers by way of Conference Call Duration per day: 24-MAY-2011 from 04:00 to 05:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Plaintiff Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-4000 representing Defendant Comments: GSK suggested going ahead with the trial in T-2101-09 and T-643-10 in April 2013. The Court will ensure that those dates are still available for 30 days Ms. Hitchman will speak to Mr. Sprigings to confirm that 30 days are appropriate duration. Parties will discuss ramifications of this change in plans and the Court suggests having a further CMC in person in Toronto to discuss this further. Mr. Kierans will write by June 8 re: advisability of a CMC in person Minutes of Hearing entered in Vol. 844 page(s) 286 - 290 Abstract of Hearing placed on file

Letter from GSK dated 10-MAY-2011 in response to Apotex's letter dated May 6, 2011 received on 10-MAY-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 13-May-2011 placed on file on 13-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 13-MAY-2011 directing that "A case management teleconference is scheduled to take place on May 24, 2011 at 4:00 p.m." placed on file on 13-MAY-2011 Confirmed in writing to the party(ies)

E-mail from Apotex advising of availability for CMC placed on file on 11-MAY-2011

Letter from Glaxo dated 12-MAY-2011 providing availability for CMC received on 12-MAY-2011

****** CANCELLED ****** Letter from Counsel for Pharmascience - Carol Hitchman dated 11-MAY-2011 "Further to the direction of Prothonotary Tabib of today's date, counsel for Pharmascience is available on the following dates to attend a case management teleconference..." cc to all parties received on 11-MAY-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated May 11, 2011. placed on file on 11-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 11-MAY-2011 directing that "By close of business on May 12, 2011 parties are to provide their availability for the weeks of May 16, 23 and 30, 2011 to attend a case management teleconference to discuss the scheduling of the trial." placed on file on 11-MAY-2011 Confirmed in writing to the party(ies)

Letter from Defendant dated 09-MAY-2011 in response to Mr Kieran's letter dated May 4, 2011. received on 09-MAY-2011

Letter from Apotex dated 06-MAY-2011 in response to GSK's letter dated 4-May-2011 received on 09-MAY-2011

Communication to the Court from the Registry dated 06-MAY-2011 re: Glaxo's letter dated 4-May-2011 sent to the CMJ and the Jud. Adm.

Letter from GSK dated 04-MAY-2011 addressed to the Judicial Administrator and the CMJ received on 04-MAY-2011

Acknowledgment of Receipt received from All parties with respect to Doc. #29 (Order from Aronovitch, P. dated May 2, 2011). placed on file on 03-MAY-2011

Order dated 02-MAY-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from "GSK" dated 08-APR-2011 Result: 1. A timetable be set for this proceeding as follows: (a) The parties shall provide the Court with a quarterly status report, the first of which to be prepared by GlaxoSmithKline Inc. by April 29, 2011. (b) The parties shall exchange answers to undertakings and questions taken under advisement and/or refused from the first round discovery by June 15, 2011. (c) The parties shall serve and file a Notice of Motion together with a schedule setting out a list of all disputed questions by July 15, 2011. (d) The parties shall meet in mid-July - mid-August 2011 to discuss the disputed questions and to narrow the questions in dispute. (e) The GlaxoSmithKline Inc. parties shall move to amend its pleadings by writing to the Court seeking an order on consent or by serving and filing a Notice of Motion to amend its pleading by July 15, 2011. (f) The parties shall provide the Court with a quarterly update report to be prepared by Apotex Inc. by July 29, 2011. (g) The motion records for the moving parties for the motions on disputed questions shall be served and filed by August 22, 2011. (h) The motion records for the responding parties for the motions on disputed questions shall be served and filed by September 7, 2011. (i) The refusal motions arising out of the first round of discovery will be heard for 4-5 days in Toronto, on September 21-23, 2011 and on September 26 and 27, 2011, if necessary. (j) The parties shall provide the Court with a quarterly update report to be prepared by Pharmascience Inc. in T-2101-09 by October 29, 2011. (k) The parties shall exchange answers to questions ordered to be answered by October 31, 2011. (l) The parties shall write to the Court by November 18, 2011 providing dates for second round discoveries of all parties' representatives, which shall be completed by January 31, 2012. (m) The parties shall write to the court by November 18, 2011 to request a case conference to be scheduled during the first 2 weeks of December 2011, to discuss the remaining pre-trial steps in these actions and set a timetable up to trial. (n) The parties shall provide the Court with a quarterly update report to be prepared by Pharmascience Inc. in T-643-10 by December 30, 2011. Filed on 02-MAY-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1122 page(s) 304 - 306 Interlocutory Decision

Communication to the Court from the Registry dated 02-MAY-2011 re: letter dated 28-Apr-2011 sent electronically to the Court

Letter from GlaxoSmithKline Inc. et al dated 28-APR-2011 We represent GlaxoSmithKline Inc. et al., and are writing on bhalf of all parties to these proceedings. We ask that this letter be brought to the attention of Madam Prothonotary Aronovitch, the case Management Judge. pursuant to the case management conference held on March 29, 2011 and draft scheduling orders filed on April 8, 2011, we are writing to provide the quarterly status report for the period ending April 29, 2011. We confirm that the first round of examinations for discovery was completed on April 4, 2011 for all parties. The parties are currently working on preparing answers to undertakings to meet the june 15, 2011 deadline as provided in the draft scheduling orders. received on 28-APR-2011

Communication to the Court from the Registry dated 13-APR-2011 re: Apotex's letter dated April 12, 2011

Letter from Apotex dated 12-APR-2011 in response to GSK's letter dated 8-Apr-2011 and attaching minutes of the CMC which was held on March 29, 2011 received on 12-APR-2011

Communication to the Court from the Registry dated 11-APR-2011 re: the minutes of the CMC and the draft orders re: timetable

Letter from Glaxo dated 08-APR-2011 re: the minutes of CMC and draft order re: proposed timetable and asking the Court to determine two issues that the parties have not been able to agree on received on 08-APR-2011

Draft Order concerning proposed timetable per CMC held 29-Mar-2011 on behalf of Glaxo received on 08-APR-2011

Minutes of the case management conference held 29-Mar-2011 received on 08-APR-2011

Ottawa 29-MAR-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss schedule to trial Result of Hearing: Minutes of the CMC and draft order on consent to be submitted by Glaxo by April 8, 2011 held in Court by way of video conference Senior Usher: S. Patry Duration per day: 29-MAR-2011 from 02:10 to 04:15 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 29-MAR-2011 from 02:10 to 04:15 Courtroom : Videoconference Room - Toronto Court Registrar: Yoginder Gulia Total Duration: 2h Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Plaintiff Jordana Sanft and Jane Caskey 416-216-4798 representing Defendant Comments: See comments in T-2101-09 Minutes of Hearing entered in Vol. 841 page(s) 61 - 62 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 24-MAR-2011 re: the parties' submissions dated March 21 and 22, 2011 re: assessment of length of trial etc..in preparation for the CMC 29-Mar-2011

Letter from Apotex Inc. dated 22-MAR-2011 providing submissions re: assessment of length of trial, statement of the issues for trial etc.. for the CMC scheduled to take place on 29-Mar-2011 received on 22-MAR-2011

Letter from Glaxo dated 21-MAR-2011 providing submissions as to assessment of length of trial and timetable to trial in preparation for the CMC to be held on March 29, 2011 received on 21-MAR-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-Mar-2011 placed on file on 07-MAR-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-MAR-2011 directing that the case management conference originally scheduled to take place by video conference on March 29, 2011 at 10:00 is now rescheduled to take place by video conference on March 29, 2011 at 2:00 p.m. for 2.5 hours placed on file on 07-MAR-2011 Confirmed in writing to the party(ies)

Letter from Glaxo dated 01-MAR-2011 further to the November 15, 2010 Order and the February 9, 2011 direction confirming availability of parties for a CMC to discuss timetable and trial dates received on 01-MAR-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 18-Feb-2011 placed on file on 21-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 18-FEB-2011 directing that a case conference to fix a timetable for the remainder of the proceeding and assess the lenght of trial for the three actions will take place, by videoconference, on March 29, 2011 for 2.5 hours commencing at 10:00 a.m. By March 22, 2011, parties are to file their assessment of the lenght of the trial of their own proceeding, as pleaded, by way of a statement of the issues for trial, and the evidence to be adduced in respect of the issues on which they bear the burden. In addition, parties will serve and file detailed timetables up to including the exchange of rebuttal expert evidence. placed on file on 18-FEB-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 17-FEB-2011 re: parties' availability for an in person CMC in Toronto

E-mail from counsel for Apotex advising of their availability on 14-Apr-2011 for an in person CMC received on 17-FEB-2011

E-mail from counsel for Glaxo providing availability for CMC on 14-Apr-2011 received on 17-FEB-2011

E-mail from counsel for Glaxo providing availability of counsel for the week of March 28 received on 11-FEB-2011

E-mail from Apotex providing availability for the week of March 28 for an in person CMC in Toronto received on 11-FEB-2011

Acknowledgment of Receipt received from all parties with respect to direction dated 09-Feb-2011 placed on file on 11-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 09-FEB-2011 directing that parties are to provide their availability to attend a 2 hour case conference in Toronto during the weeks of March 28 or April 14, 2011, to finalize timetables with the object of securing trial dates for the trial of the actions together or consecutively by the same judge placed on file on 09-FEB-2011 Confirmed in writing to the party(ies)

Memorandum to file from Julie Dulac dated 23-DEC-2010 the parties have indicated that sending directions and order by e-mail is appropriate in this file: for the plaintiff jtopolski@goodmans.ca, kcrofoot@ goodmans.ca and for the defendants pkierans@ogilvyrenault.ca, jsanft@ogilvy renault.ca, kaguilera@ogilvyrenault.ca placed on file.

Acknowledgment of Receipt received from Mr. Topolski & Ms. Sanft with respect to the Written Direction from Aronovitch, P. dated Dec/9/2010. placed on file on 10-DEC-2010

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 09-DEC-2010 directing that 1. The examination for discovery of GlaxoSmithKline Inc. et al.'s (collectively, "GSK") corporate representative, Dr. Tom Krenitsky, shall be held on February 23-25, 2011. 2. The examination for discovery of GSK's corporate representative, Ms. Cindy Roll, shall be held on February 8-9, 2011. 3. The examination for discovery of GSK's corporate representative, Mr. Norm Vojir, shall be held on March 9-10, 2011. 4. The examination for discovery of Apotex Inc.'s corporate representative shall be held on March 22-24, 2011. placed on file on 09-DEC-2010 Confirmed in writing to the party(ies)

Letter from Defendant dated 30-NOV-2010 providing a draft direction setting dates agreed upon by the parties for the first round of examinations for discovery received on 01-DEC-2010

Proof of Service of Fax received from Mr. Topolski & Mr. Aguilera with respect to Doc. #28 (Order from Aronovitch, P. dated Nov/15/2010) placed on file on 16-NOV-2010

Order dated 15-NOV-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The first round of examinations for discovery shall be completed by March 31, 2011. 2. Dates for the first round of examinations for discovery shall be fixed by November 30, 2010, and the parties shall write jointly to the Court by that date to advise of the dates so fixed. 3. By no later than March 1, 2011, the defendant and plaintiffs by counterclaim shall request a case conference and provide the availability of counsel for all parties to attend same during the weeks of March 28 and April 4, 2011 to set a trial date for the within proceeding. Filed on 16-NOV-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1105 page(s) 296 - 297 Interlocutory Decision

Communication to the Court from the Registry dated 15-NOV-2010 re: the draft order re: CMC 9-Nov-2010

Draft Order concerning CMC held on 09-Nov-2010 received on 10-NOV-2010

Ottawa 09-NOV-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss a timetable for the matter Result of Hearing: Ms Sanft is to provide the Court with a draft timetable on Wednesday November 10, 2010 held by way of Conference Call Duration per day: 09-NOV-2010 from 11:00 to 11:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 30min Appearances: Mr. Topolski and Mr. Crofoot 416-979-2211 representing Plaintiff Mr. Kierans, Ms Sanft and Mr. Bandourina 416-216-3904 representing Defendant Minutes of Hearing entered in Vol. 833 page(s) 86 - 89 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 09-NOV-2010 re: preparation of the file for the CMC on November 9, 2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-OCT-2010 directing that a case management teleconference will take place on November 9, 2010 at 11:00 a.m. placed on file on 20-OCT-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 19-OCT-2010 re: the availability of the parties for a CMC

Letter from Plaintiff dated 18-OCT-2010 advising of its availability for a CMC received on 18-OCT-2010

Letter from defendants dated 19-OCT-2010 advising of their availability for a CMC received on 19-OCT-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 15-OCT-2010 directing that "I have concerns regarding both revised timetables submitted by the parties (correspondence of October 8 and 12, 2010). Accordingly, by no later than October 20, 2010, parties are to provide their availability to attend a case conference during the weeks of October 25 and November 8, 2010 to set a timetable to accelerate the prosecution of this action." placed on file on 15-OCT-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-OCT-2010 re: GSK's submissions dated 8-Oct-2010 and Apotex' submissions dated 12-Oct- 2010

Letter from Plaintiff dated 12-OCT-2010 in response to the Court's direction dated 29-Sep-2010 and GSK's submissions dated 08-Oct-2010 received on 12-OCT-2010

****** REMOVED ****** Copy of a Letter from the defendant in T-2101-09 dated 12-OCT-2010 in response to the Court's direction dated 29-Sep-2010 and GSK's submissions dated 08-Oct-2010 received on 12-OCT-2010

Letter from GSK dated 08-OCT-2010 providing a proposed timetable further to the direction of the Court dated 29-Sep-2010 received on 08-OCT-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-SEP-2010 directing that "The discussions with respect to consolidation if any, of these files is not meant to effect a stay of these proceedings. By October 8, 2010, GSK is to file a status report on each of these files and propose a timetable or amendments to an existing timetable for each. If not on consent, parties opposite are to respond by October 12, 2010 and request case conferences which will be held separately in any file where there is no consent to a timetable." placed on file on 29-SEP-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-SEP-2010 re: counsel's correspondence dated Sept 3, 2010 and Sept 7, 2010

****** CANCELLED ****** Communication to the Court from the Registry dated 10-SEP-2010 re: counsel's correspondence dated 3-Sep-2010 and 7-Sep-2010

****** REMOVED ****** Letter from Plaintiff dated 07-SEP-2010 in response to GSK's letter dated 3-Sep-2010 received on 07-SEP-2010

Letter from the defendants in T-2101-09 dated 07-SEP-2010 in response to GSK's letter dated 3-Sep-2010 received on 07-SEP-2010

Letter from GSK dated 03-SEP-2010 Requesting the Court an extension on time until September 30, 2010 to comply with the Direction of Madam Aronovitch dated July 23, 2010. received on 03-SEP-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-AUG-2010 directing that Further to Ms. Sanft's letter dated August 27, 2010, requesting until September 9, 2010 to report on discussions regarding consolidation: "Granted" placed on file on 30-AUG-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 30-AUG-2010 re: GSK's letter dated 27-Aug-2010

Letter from GSK dated 27-AUG-2010 requesting an extension until September 9, 2010 to comply with the July 23, 2010 direction received on 27-AUG-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 23-JUL-2010 directing that "By the end of August 2010, the parties are to meet to see if they can find common ground with respect to any consolidation of the three actions at any point in the proceedings. By September 3, 2010, Mr. Kierans is to advise the Court as to any consensus of the parties' and in the alternative provide a date by which he will be serving and filing a motion to consolidate if any." placed on file on 23-JUL-2010 Confirmed in writing to the party(ies)

Ottawa 22-JUL-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the issue of consolidation for trial Result of Hearing: Direction to follow held by way of video conference Senior Usher: P. Gendron Duration per day: 22-JUL-2010 from 02:08 to 03:30 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 1.5h Appearances: Jerry Topolski 416-597-5907 representing Apotex Patrick Kierans, Jordana Sanft and Keith Aguilera 416-216-4000 representing GSK et als Comments: Heard with T-2101-09 and T-643-10 Minutes of Hearing entered in Vol. 827 page(s) 430 - 433 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of the submissions dated 12-Jul-2010 from GSK upon all parties by telecopier on 12-JUL-2010 filed on 12-JUL-2010

Communication to the Court from the Registry dated 19-JUL-2010 re: in preparation for the CMC scheduled on 22-Jul-2010

****** REMOVED ****** Letter from Plaintiffs in T-2101-09 and T-643-10 dated 12-JUL-2010 in response to the Court's direction dated 10-Jun-2010 received on 12-JUL-2010

Letter from GSK dated 12-JUL-2010 in response to the Court's direction dated 10-Jun-2010 received on 12-JUL-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 12-JUL-2010 directing that Accept the document submitted on July 12, 2010 for filing placed on file on 12-JUL-2010

Letter from Plaintiff (Apotex Inc.) dated 12-JUL-2010 This letter is responding to the direction issued June 10th 2010. received on 12-JUL-2010

Communication to the Court from the Registry dated 05-JUL-2010 re: GSK's letter dated 30-Jun-2010

Memorandum to file from Julie Dulac dated 05-JUL-2010 further to the receipt of counsel for GSK's letter dated 30-Jun-2010, I advised the parties that Madam Aronovitch is away until July 12, 2010 and that the correspondence will be placed before her upon her return and that in case of a request to vary a timeline, if the parties are able to agree, they are to abide by the agreed timeline as if she had endorsed it. The Order or direction will be issued upon her return placed on file.

Letter from GSK dated 30-JUN-2010 requesting an extension of time, on consent, to provide the Court with submissions with regards to consolidation until July 12, 2010 received on 30-JUN-2010

Affidavit of service of Annelise Malandrino sworn on 17-JUN-2010 on behalf of Plaintiff confirming service of Doc 25 upon all parties by telecopier on 17-JUN-2010 filed on 17-JUN-2010

Amended REPLY AND DEFENCE TO COUNTERCLAIM filed on 17-JUN-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 10-JUN-2010 directing that "A case management conference by video conference will take place on July 22, 2010 commencing at 2:00 p.m. for 1.5 hours. For that purpose, by July 5, 2010, parties are to serve and file a statement of the issues for the trial in their proceeding; advantages and economies that might be realized by consolidating the hearings and impediments or problems, if any, to overcome." placed on file on 10-JUN-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 09-JUN-2010 re: counsel for GSK's letter dated June 4, 2010

Letter from GSK dated 04-JUN-2010 is response to the Direction dated May 27, 2010 providing their availability for a CMC received on 04-JUN-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-MAY-2010 directing that In light of the correspondence dated May 25, 2010 from Ms. Hitchman, the motion to be heard on July 20, 2010 is hereby adjourned sine die. The reply & defence to counterclaim are to be filed in accordance with the Rules. The dates proposed for a case conference are not available to the Court. As there are limited dates available in June parties should consider the weeks of July 12 and 19, 2010. As counsel in T-643-10 ought to be included in the consolidation discussion, the plaintiff is requested, by June 4, 2010 to file the dates of availability of all counsel during the weeks of July 12 and 19, 2010. placed on file on 27-MAY-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 27-MAY-2010 re: availability of parties for a CMC to discuss consolidation and trial dates and the fact that the motion to strike will not be filed by the defendant therefore no need for hearing date on July 20, 2010 and paragraph 1(a) of the May 18th Order needs to be amendedand request in T-643-10 that the file be case managed by Madam Aronovitch was sent up to the Judicial Administrato

Letter from Plaintiff dated 21-MAY-2010 in response to court's directions dated 19-May-2010. Counsel for Apotex Inc. Plaintiff, is available for CMC any time on June 1,8,9,10,11,14,15,16,17 and 17. received on 21-MAY-2010

Letter from counsel for GSK dated 21-MAY-2010 providing availability for CMC to discuss consolidation and securing trial dates received on 21-MAY-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-MAY-2010 directing that the hearing scheduled May 31, 2010 is adjourned dine die placed on file on 20-MAY-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 20-MAY-2010 re: the defendant's letter dated May 19, 2010

Letter from Defendant dated 19-MAY-2010 advising that in light of the Order dated May 14, 2010 the parties will no longer require the May 31, 2010 motion hearing date set by the Order of April 8, 2010 received on 19-MAY-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-MAY-2010 directing that By May 21, 2010, parties are to provide their availability to attend a joint case management conference by videoconference for a duration of 1.5 hours, to discuss consolidating the proceeding for the purposes of hearing, that is consecutively, by the same judge, and the possibility of securing trial dates. Parties are to provide their availability for the weeks of May 31, June 7 and 14, 2010." placed on file on 19-MAY-2010 Confirmed in writing to the party(ies)

Solicitor's certificate of service on behalf of defendant confirming service of doc.23 upon Plaintiff by personal service on 18-MAY-2010 filed on 18-MAY-2010

Amended Defence and Counterclaim filed on 18-MAY-2010

Affidavit of service of Annelise Malandrino sworn on 14-MAY-2010 on behalf of Plaintiff confirming service of doc 21 upon Defendant by telecopier on 14-MAY-2010 filed on 14-MAY-2010

Amended Statement of Claim filed on 14-MAY-2010

Order dated 14-MAY-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendant dated 10-MAY-2010 Result: THIS COURT ORDERS that: 1. The plaintiff (defendant by counterclaim) may file and serve the Amended Statement of Claim no later than five (5) days after the date of this Order. 2. The defendant (plaintiff by coutnerlcaim) may file and serve the Amended Statement of Defence and Counterclaim no later than five (5) days after service of the Amended Statement of Claim described paragraph 1, above. Filed on 14-MAY-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1088 page(s) 429 - 431 Interlocutory Decision

Letter from Defendant dated 10-MAY-2010 providing the Court with a draft order on consent to amend the pleadings. received on 10-MAY-2010

Communication to the Court from the Registry dated 04-MAY-2010 re: letter from the defendant dated April 29, 2010

Letter from Defendant dated 29-APR-2010 indicating that parties have agreed to the filing of amended pleadings and requesting directions on how to have the requisite Order issued received on 29-APR-2010

Order dated 08-APR-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Order dated 03-MAR-2010 Result: The timetable for this proceeding is as follows: (a) Any outstanding motions respecting the pleadings in this proceeding shall be served and filed no later than April 30, 2010; (b) Any response to the motions referred to in (a) shall be filed and served no later than May 21, 2010; (c)_The motions will be heard in Toronto, on May 31, 2010, consecutively, for 4 hours, commencing at 9:30 a.m.; (d) Examinations for discovery shall be completed no later than October 15, 2010; (e) Answers to undertakings made during the examinations for discovery shall be exchanged by December 15, 2010; (f) Any notices of motion with a list of questions attached arising from the examinations for discovery shall be served and filed no later than January 14, 2010; and (g) The plaintiff shall serve and file a report on progress against this timetable by October 22, 2010 and again by December 22, 2010. Filed on 08-APR-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1084 page(s) 493 - 494 Interlocutory Decision

Ottawa 07-APR-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: The Court will issue the proposed timetable with some changes: The date for the hearing of the motions to amend the pleadings has been set to May 31, 2010 for 4 hours, and the Court will make a change to par. e) to indicate that only the notice of motion need be filed and she removes par. f) held in chambers by way of Conference Call Duration per day: 07-APR-2010 from 04:00 to 04:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Dino Clarizio, Ken Crofoot and Jerry Topolski 416-597-4140 representing Plaintiff Patrick Kierans 416-216-3904 representing Defendant Comments: Mr. Kierans will seek instructions with his client re: consolidation of this file and T-2101-09 and will speak to counsel for the other side in this file and in T-2101-09 re: same Minutes of Hearing entered in Vol. 821 page(s) 223 - 225 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 07-APR-2010 re: the Defendant's letter dated April 6, 2010 and attached draft order

Letter from Defendant dated 06-APR-2010 attaching a draft scheduling order consented to by the Plaintiff received on 07-APR-2010

Communication to the Court from the Registry dated 06-APR-2010 re: in preparation for the CMC on April 7, 2010

Order dated 03-MAR-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: THIS COURT ORDERS that: 1. The parties are granted an extension of time for exchanging their respective Affidavits of Documents and productions therein to March 19, 2010. 2. There will be a further case management teleconference held on April 7, 2010 at 4:00 for one hour to: (a) Set a timetable for the examinations for discovery, including a timetable for the exchanging of undertakings and scheduling of refusals motions. (b) Address a timetable for any outstanding motions. 3. The parties are to prepare a proposed joint timetable, agreed to on consent, regarding (a) and (b) above and electronically submit it to the Court by April 6, 2010. Filed on 03-MAR-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1081 page(s) 359 - 360 Interlocutory Decision

Letter from Defendant dated 02-MAR-2010 providing the Court with a draft order on consent of a timetable received on 02-MAR-2010

Ottawa 02-MAR-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the timetable in the matter Result of Hearing: The parties are to produce a timetable on consent and submit it to Court by April 6, 2010. A case conference will be held on April 7, 2010 to finalize the timetable that will be submitted on April 6, 2010. held by way of Conference Call Duration per day: 02-MAR-2010 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 35min Appearances: Mr. Crofoot 416-979-2211 representing Plaintiff Ms Sanft and Mr. Kierans 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 819 page(s) 191 - 194 Abstract of Hearing placed on file

Memorandum to file from Annette Houle, Ottawa dated 26-FEB-2010 The parties were informed by telephone that the request to adjourn the case conference on March 2,2010 was denied. placed on file.

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-FEB-2010 directing that The request to adjourn the case conference on March 2, 2010 is denied. placed on file on 26-FEB-2010

Letter from Defendant dated 26-FEB-2010 re: extending deadlines for Aff of Documents and rescheduling the March 2nd CMC. received on 26-FEB-2010

****** CANCELLED ****** Order dated 22-FEB-2010 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 23-DEC-2009 Result: 1. This proceeding shall continue as a specially managed proceeding. 2. The plaintiff, within 20 days of the date of this order, shall serve and file a proposed timetable for the completion of the steps necessary to advance the proceeding in an expeditious manner. 3. The plaintiff shall consult with the defendant prior to the filing of the proposed timetable and indicate with its filing whether the timetable has been consented to by the defendant. 4. Pursuant to Rule 383, Prothonotary Roza Aronovitch is assigned as Case Management Judge in this matter. Filed on 22-FEB-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1080 page(s) 242 - 243 Interlocutory Decision

Communication to the Court from the Registry dated 18-FEB-2010 re: preparation of the file for the case conference scheduled for March 2, 2010

Order dated 04-JAN-2010 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: "1. The parties are to exchange their respective Affidavits of Documents and productions therein by 19-FEB-2010. 2. There will be a further case management teleconference on 2-MAR-2010 at 10:00 a.m. to discuss the scheduling of examinations for discovery." Filed on 04-JAN-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1076 page(s) 64 - 65 Interlocutory Decision

Ottawa 23-DEC-2009 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss letters dated November 20, 2009 and December 17, 2009 Result of Hearing: Mr. Crofoot is to provide the Court with a timetable by December 30, 2009 held by way of Conference Call Duration per day: 23-DEC-2009 from 10:00 to 10:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 50min Appearances: Mr. K. Crofoot 416-979-2211 representing Plaintiff Mr. P Kierans 416-216-3904 representing Defendant Comments: Mr. Kierans to write to Court to have T-2101-09 case managed. Mr. Kierans to bring a motion for consolidation. Apotex opposes consolidation. Minutes of Hearing entered in Vol. 815 page(s) 457 - 461 Abstract of Hearing placed on file

Letter from Defendant dated 17-DEC-2009 see attached St. of Claim on T-2101-09 to be added to the agenda on 23-Dec-0 received on 17-DEC-2009

Communication to the Court from the Registry dated 10-DEC-2009 re: preparation of the file for the CMC on December 23, 2009

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 08-DEC-2009 directing that The case management conference scheduled for December 14, 2009 is hereby adjourned to December 23, 2009, commencing at 10:00 a.m. for one hour. placed on file on 08-DEC-2009 Confirmed in writing to the party(ies)

Protective Order dated 07-DEC-2009 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 20-NOV-2009 Result: See Order for details Filed on 07-DEC-2009 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1073 page(s) 358 - 364 Interlocutory Decision

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-DEC-2009 directing that There will be a case management conference by teleconference on December 2009, commencing at 3:00 p.m. for one hour. placed on file on 07-DEC-2009 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 30-NOV-2009 re: letter from the plaintiff dated November 20, 2009

Letter from Plaintiff dated 20-NOV-2009 Agreed schedule of the parties, draft protective order, & dates for a CMC received on 20-NOV-2009

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 16-NOV-2009 directing that By no later than November 20, 2009 parties are to serve and file separate or joint timetables for the prosecution of this action. In the alternative by the same date, parties may request a case management conference to discuss a timetable and any other preliminary matters, and are to provide their availability to attend the case conference during the two weeks following the date of the correspondence. Case management correspondence is to be e-mailed to CMT_Ottawa@cas-satj.gc.ca placed on file on 16-NOV-2009 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 06-NOV-2009 re: Order of the Court dated October 30, 2009

Order dated 30-OCT-2009 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Status Review Result: Pursuant to Rule 383 that Prothonotary Roza Aronovitch is assigned as Case Management Judge in this matter. Filed on 02-NOV-2009 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1070 page(s) 65 - 65 Interlocutory Decision

Communication to the Court from the Registry dated 23-OCT-2009 re: File sent to Trial JA re: letter dated October 19, 2009 request to appoint a Case Management Judge.

Letter from Plaintiff dated 19-OCT-2009 We are the solicitors for Apotex Inc. with consent of the Defendant we request that the within proceeding be designated as case managed and a case management Judge and Prothonotary be assigned. received on 19-OCT-2009

Affidavit of service of Annelise Malandrino sworn on 26-MAR-2009 on behalf of Plaintiff confirming service of the letter dated March 26, 2009 upon Defendant by e-mail on 26-MAR-2009 filed on 27-MAR-2009

Letter from Plaintiff dated 26-MAR-2009 with attached Schedule A to the Reply and Defence to Counterclaim received on 27-MAR-2009

Affidavit of service of ANNELISE MALANDRINO sworn on 26-MAR-2009 on behalf of Plaintiff confirming service of DOC 11 upon Defendant by telecopier on 26-MAR-2009 filed on 26-MAR-2009

REPLY AND DEFENCE TO COUNTERCLAIM filed on 26-MAR-2009

Solicitor's certificate of service on behalf of Jordana Sanft confirming service of Doc #9 upon Plaintiff by electronic copy on 24-FEB-2009 filed on 24-FEB-2009

Defence and Counterclaim filed on 24-FEB-2009

****** CANCELLED ****** Solicitor's certificate of service on behalf of Jordana Sanft confirming service of Statement of Defence and Counterclaim upon Plaintiff by personal service on 25-FEB-2009 filed on 25-FEB-2009

Correction to General Sitting concerning Motion Doc. No. 2 Hearing removed from General Sitting at Toronto on 23-FEB-2009 Reason for correction: Defendant withdraws the motion on consent without costs.

Letter from Defendant dated 11-FEB-2009 Withdrawing motion for particulars and for extension of time (doc.2) filed 4-Feb-2009, on consent without costs. received on 11-FEB-2009

Consent on behalf of Plaintiff to extension of time for Defendant to file Statement of Defence. filed on 09-FEB-2009

Adjournment telephone call received on 06-FEB-2009 from Graham McNeil on behalf of Defendant concerning Motion Doc. No. 2 currently scheduled to be heard at General Sitting on 09-FEB-2009 now adjourned to General Sitting in Toronto on 23-FEB-2009 to begin at 09:30 duration: 1h 30min language: E

Solicitor's certificate of service on behalf of Jordana Sanft confirming service of doc 5 upon Plaintiff by personal service on 04-FEB-2009 filed on 04-FEB-2009

Motion Record containing the following original document(s): 2 3 4 Number of copies received: 3 on behalf of Defendant filed on 04-FEB-2009

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 2 filed on 04-FEB-2009

Affidavit of J. Ross Deboni sworn on 04-FEB-2009 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 2 with Exhibits A-C filed on 04-FEB-2009

Notice of Motion contained within a Motion Record on behalf of Defendant returnable at General Sitting in Toronto on 09-FEB-2009 to begin at 09:30 duration: 1h 30min language: E for an Order pursuant to rule 181(2) requiring the Plaintiff to provide further & better particulars...; permitting the Defendant to file its Statement of Defence within 20 days after I) the receipt of the particulars subject to the order or II) the final disposition of the motion (Jordana Sanft 416-216-4000) filed on 04-FEB-2009

Statement of Claim filed on 06-JAN-2009 Tariff other action - $150.00